USPTO Patent Grant: Composition for Improving Muscle Function
The USPTO has granted patent US12582623B2 to N.V. Nutricia for a composition comprising EPA, MA, and leucine. This composition is intended for the prevention and/or treatment of diseases involving muscle decline or for improving muscle function.
USPTO Grants Patent for Sodium Oxybate to Treat Idiopathic Hypersomnia
The United States Patent and Trademark Office (USPTO) has granted patent US12582622B2 to Jazz Pharmaceuticals Ireland Limited for methods of treating idiopathic hypersomnia with sodium oxybate. The patent is effective March 24, 2026.
USPTO Patent Grant for Viral Infection Compounds Targeting Sigma Receptors
The USPTO has granted a patent (US12582619B2) to Thomas Jefferson University for compounds that modulate Sigma receptors to treat viral infections. The patent covers methods for preventing, treating, or ameliorating viral infections using these compounds, potentially in combination with other therapeutic agents.
USPTO Grants Patent for Benzothiazole Compound for Parkinson's and Restless Leg Syndrome
The USPTO has granted a patent (US12583829B2) to Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. for a salt of a benzothiazole compound and its crystal form. The patent covers the use of this compound in the preparation of drugs for treating Parkinson's disease and restless leg syndrome.
USPTO Patent Grant for GIP Receptor Antibodies
The USPTO has granted patent US12583930B2 to Crystal Bioscience Inc. for GIP receptor antibodies designed to treat metabolic disorders, specifically those related to glucose metabolism. The patent covers antibodies that bind to and inhibit the human glucose-dependent insulinotropic polypeptide (GIP) receptor.
USPTO Patent Grant: ARDS Treatment with G-CSF Inhibitors
The USPTO has granted patent US12583929B2 to CSL Innovation Pty Ltd for methods of treating acute respiratory distress syndrome (ARDS) using compounds that inhibit G-CSF signaling. The patent covers compounds and their use in manufacturing medicaments for ARDS prevention and treatment.
USPTO Patent for Alzheimer's Treatment Using LRP1/SorLA Antagonist
The USPTO has granted a patent (US12583920B2) to the University of Maryland, Baltimore, for methods and compositions to treat or prevent Alzheimer's disease using LRP1 and/or SorLA antagonists. The patent covers specific therapeutic approaches targeting tau internalization and trafficking in neuronal cells.
USPTO Grants Patent for Flavivirus Cross Neutralizing Antibody
The USPTO has granted patent US12583912B2 for a flavivirus cross-neutralizing antibody developed by the Japan Institute for Health Security. This antibody specifically targets the E protein of flaviviruses, including Zika, dengue, and Japanese encephalitis viruses, and aims to control infection with suppressed Antibody-Dependent Enhancement (ADE).
USPTO Patent Granted for Cognitive Disorder Treatment Compound
The USPTO has granted patent US12583884B2 to AELIS FARMA for a compound, 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one, for use in treating cognitive disorders. The patent filing date was December 18, 2019.
USPTO Patent Grant: Immunopotentiating Amino Acid Mineral Complex
The USPTO has granted a patent (US12583873B2) to BTN CO., LTD. for an amino acid mineral complex with immunopotentiating activity. This complex can be used in compositions for foods, pharmaceuticals, or feeds to enhance immunity or antibody production in humans and animals.
USPTO Patent Grant: Tumor Treatment with Antibodies
The USPTO has granted patent US12582713B2 to Bristol-Myers Squibb Company for methods of treating tumors using pharmaceutical compositions containing anti-PD-1 or anti-PD-L1 antibodies, particularly for subcutaneous delivery. The patent also covers compositions that include an endoglycosidase hydrolase enzyme.
USPTO Grants Patent for Glutathione Trisulfide in Neuroprotection
The USPTO has granted a patent (US12582693B2) to The General Hospital Corporation for methods using glutathione trisulfide (GSSSG) in neuroprotection. The patent covers uses in treating neurodegenerative diseases and reducing ischemic injury risk.
USPTO Patent Grant: Botulinum Toxin for Infertility Treatment
The USPTO has granted a patent (US12582705B2) to CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION for a composition comprising botulinum toxin or a salt thereof. This composition is intended to increase endometrial blood flow and improve implantation potential, potentially treating subfertility or infertility.
Patent for Crohn's Disease Indicator and Treatment
The USPTO has granted Washington University a patent (US12582696B2) for methods to treat, select, and monitor inflammatory bowel disease using Debaryomyces species as a biomarker. The treatment involves administering an antifungal compound and detecting fungal DNA or antibodies.
USPTO Patent Grant: Peptides for Treating Glioma Tumors
The USPTO has granted patent US12582695B2 for peptides, compositions, and methods to treat glioma tumors infiltrated with macrophages. The patent was filed on November 27, 2019, and is assigned to Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk.
USPTO Grants Patent for Compounds Inhibiting Protozoan Parasites
The USPTO has granted a patent (US12582694B2) to the University of South Florida for compounds and methods designed to block protozoan parasite invasion and liver-stage development, specifically mentioning Plasmodium falciparum. This patent covers novel therapeutic approaches for treating parasitic infections.
USPTO Patent Grant US12582691B2: Yunnan Baiyao/Xingnaojing for TBI
The USPTO has granted patent US12582691B2 to Lotus Biotech.com LLC for methods of administering Yunnan Baiyao or Xingnaojing to patients with moderate-to-severe traumatic brain injury (TBI) and craniotomy. The patent covers methods for improving postoperative recovery and inhibiting adverse impacts associated with TBI and related neurological conditions.
USPTO Patent Grant: Cancer Treatment Compositions
The USPTO has granted a patent (US12582690B2) to the Korea Institute of Science and Technology for compositions containing Rubus longisepalus var. tozawai extracts for preventing or treating cancer. The patent details specific anticancer efficacy against various cancers, including diffuse-type gastric cancer.
USPTO Grants Patent for Terpenoids in Fibrotic Disease Treatment
The USPTO has granted patent US12582689B2 to ARJIL BIOTECH HOLDING COMPANY LIMITED for a method of treating or preventing fibrotic diseases using terpenoids extracted from Antrodia-camphorate or Anisomeles indica. The patent was granted on March 24, 2026.
USPTO Patent Grant: Bone Fracture Recovery Composition Manufacturing Method
The USPTO has granted a patent (US12582686B2) for a manufacturing method of a composition designed to promote bone fracture recovery. The method involves preparing and processing a specific mixture of herbal and natural ingredients into a liquid extract.
USPTO Patent Grant: Allergy Treatment Compositions
The USPTO has granted patent US12582679B2 to Vedanta Biosciences, Inc. for compositions and methods for treating allergy, including food allergy. The patent covers novel approaches to modulating immune responses and inducing immune tolerance or desensitization.
Immunotherapy Patent for H3K27M Mutation Cancers Issued
The USPTO has issued a new patent (US12582675B2) to The Board of Trustees of the Leland Stanford Junior University for methods of treating cancers harboring an H3K27M mutation using immunotherapy. The patent details the use of immune cells engineered to express GD2-specific chimeric antigen receptors.
Vanadium Compounds Patented for Cancer Treatment
The USPTO has granted a patent (US12582672B2) to The Broad Institute, Inc. for vanadium compositions and methods for treating cancers, particularly those expressing elevated levels of SLC26A2. The patent covers the use of bis(maltolato)oxovanadium(IV) (BMOV) and related compounds.
USPTO Patent Grant: Lignin Solvation for Antimicrobial Therapeutics
The USPTO has granted a patent (US12582670B2) to the University of Florida Research Foundation, Inc. for a method of solvating lignin in aqueous buffers for use in antimicrobial therapeutics. The patent covers aqueous lignin solutions and their applications in treating microbial infections and forming antimicrobial products.
USPTO Patent US12582667B2 for Gastrointestinal Cancer Treatment
The USPTO has granted patent US12582667B2 to The Rockefeller University for compounds and methods to treat metastatic gastrointestinal cancer. The patent details a method involving suppressing the enzymatic activity of DHODH and/or decreasing creatine levels via suppression of the creatine transporter SLC6a8.
USPTO Patent Grant for Low Dose Therapeutic Treatment
The USPTO has granted patent US12582666B2 to Syqe Medical Ltd. for a low dose therapeutic treatment system. The patent covers a system for delivering predetermined amounts of THC, with specific limits on dosage and delivery time, utilizing a decision module and an inhaler device.
USPTO Patent Grant for Injectable Pharmaceutical Compositions by Zoetis
The USPTO has granted patent US12582662B2 to Zoetis Services LLC for injectable pharmaceutical compositions. The patent covers formulations including a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative, designed for effective preservation according to pharmacopoeia standards.
USPTO Grants Patent for RSV Inhibitors
The USPTO has granted a new patent (US12582661B2) to SHANGHAI ARK BIOPHARMACEUTICAL CO., LTD. for a class of respiratory syncytial virus (RSV) inhibitors. The patent, effective March 24, 2026, covers compounds with potential advantages in activity and in vivo exposure compared to existing treatments.
USPTO Patent Grant: Methods Treating Disorders Using CSFIR Inhibitors
The USPTO has granted patent US12582655B2 to Deciphera Pharmaceuticals, LLC for methods of treating cancers and other tumors using CSFIR inhibitors. The patent covers methods related to the proliferation, depletion, or repolarization of tumor-associated macrophages (TAMs).
USPTO Grants Patent for Idiopathic Pulmonary Fibrosis Treatment
The USPTO has granted a patent (US12582653B2) to BEIJING TIDE PHARMACEUTICAL CO., LTD. for a compound and method to treat idiopathic pulmonary fibrosis. The patent covers compounds represented by formula (I) and their pharmaceutically acceptable derivatives.
USPTO Patent for Hair Follicle Regeneration
The USPTO has granted Washington University a patent (US12582649B2) for compositions and methods for hair follicle regeneration using TRPV4 activating agents. The patent aims to treat hair loss conditions such as alopecia and telogen effluvium.
USPTO Patent Grant: Dopamine D3 Agonists for CNS Disorders
The USPTO has granted patent US12582648B2 to Bioprojet Pharma for a method of treating central nervous system disorders, including restless leg syndrome and neurodegenerative diseases, using dopamine D3 partial agonists. The patent details specific applications and classifications related to these therapeutic uses.
USPTO Patent US12582642B2 for Treating Bovine Papillomatosis
The USPTO has granted patent US12582642B2 to KINOPHARMA, INC. for a composition and method to treat bovine papillomatosis. The patent covers compounds represented by Formula (I) or their pharmaceutically acceptable salts.
USPTO Grants Patent for Sulfur Compound in Tumor Treatment
The USPTO has granted patent US12582641B2 to SHANGHAITECH UNIVERSITY for a sulfur-containing compound based on a glutarimide skeleton and its application in treating tumors. The patent filing date was February 25, 2020, and the grant date is March 24, 2026.
Donepezil Topical Formulation Patent for Intradermal Use
The USPTO has granted a patent (US12582637B2) to Arctic Therapeutics HF for a topical formulation of donepezil intended for intradermal application. The patent covers compositions and methods of use for this specific formulation.
USPTO Patent Granted for Cancer Treatment with ERK Inhibitors
The USPTO has granted a patent (US12582635B2) to Biomed Valley Discoveries, Inc. for methods of treating cancer with atypical BRAF mutations using ERK inhibitors. The patent covers compositions, methods for treatment, and identification of suitable patient populations.
USPTO Patent Grant for CAH Treatment Compound
The USPTO has granted patent US12582634B2 to Neurocrine Biosciences, Inc. for a compound and synthetic methods for treating congenital adrenal hyperplasia (CAH). The patent covers specific chemical structures and their preparation, aiming to provide new therapeutic options for this condition.
USPTO Patent Grant for Improving Kidney Function
The USPTO has granted patent US12582631B2 to Chinook Therapeutics, Inc. for methods of improving kidney function. The patent, which includes 36 claims, was filed on August 16, 2022, and granted on March 24, 2026.
USPTO Patent Grant: Dapansutrile for Breast Cancer Treatment
The USPTO has granted patent US12582628B2 to Olatec Therapeutics, Inc. for a method of treating breast cancer using dapansutrile, optionally in combination with a checkpoint inhibitor. The patent covers methods of treatment and has an effective date of March 24, 2026.
Nestle Patent for MCTs Improving Cognitive Function
The USPTO has granted Nestle a patent (US12582627B2) for MCT formulations designed to improve cognitive functions, such as memory and executive function, and to prevent or treat mild cognitive impairment (MCI). The patent specifies daily dosages and composition ratios of medium chain triglycerides, particularly octanoic acid.
USPTO Patent Grant US12582545B1 for Excretion Treating Apparatus
The USPTO has granted patent US12582545B1 for a cup designed for an automatic excretion treating apparatus. The patent, assigned to LIBERTYSOLUTION CO., LTD, was filed on December 17, 2021, and granted on March 24, 2026.
USPTO Grants Spinal System Patent to Genesys Spine
The USPTO has granted a patent (US12582535B2) to Genesys Spine for a stand-alone interbody spinal system. The patent details an orthopedic fusion system including a cage, channels, anchors, and a resilient member. The filing date for this patent was February 26, 2024.
USPTO Patent Grant for Flexible Implants and Instruments
The USPTO has granted patent US12582534B2 for flexible implants and instruments, assigned to VB Spine US Opco LLC. The patent describes an implant body with a flexible pattern defined by multiple material segments with non-linear shapes.
USPTO Patent Grant: Therapeutic Lasers for Ophthalmology
The USPTO has granted patent US12582553B2 to Pulsemedica Corp. for a therapeutic laser system using spatial light modulation for treating ophthalmological conditions. The patent covers technology that allows a therapeutic laser to be focused on multiple target locations simultaneously.
USPTO Patent US12582552B2: Radiant Exposure at Retina During Ophthalmic Procedure
The USPTO has granted patent US12582552B2 to Alcon Inc. for a system and method to determine radiant exposure at the retina during ophthalmic procedures. The patent describes a laser system that calculates radiant exposure based on the distance between the laser target and the retina.
USPTO Patent Grant for Eye Aqueous Drainage Devices
The USPTO has granted patent US12582551B2 to Iantrek, Inc. for methods and devices to increase aqueous drainage of the eye, specifically for treating glaucoma. The patent describes a trabeculorhexis technique that applies non-cutting shear and tension to tissue, aiming to reduce incisional bleeding and tissue damage.
USPTO Grants Patent for Therapeutic Gas Delivery Cart
The USPTO has granted a design patent (USD1120338S1) for a therapeutic gas delivery cart to Mallinckrodt Pharmaceuticals Ireland Limited. The patent, which covers the design of the cart, was granted on March 24, 2026, with a filing date of June 17, 2025.
USPTO Patent Grant US12582542B2 for Orthopedic Aid Rod
The USPTO has granted patent US12582542B2 for a stabilizing rod for an orthopedic aid, assigned to Bauerfeind AG. The patent describes a rod with a flexible section featuring at least one material cut-out.
USPTO Patent Grant: Cryotherapy and compression sleeve
The USPTO has granted patent US12582541B2 for a cryotherapy and compression sleeve. The patent, assigned to FREEZE SLEEVE IPCO LLC, covers a device designed to provide evenly distributed hot or cold temperature application and compression therapy without clips or buckles.
USPTO Glove Design Patent Grant USD1119165S1
The USPTO has granted a design patent (USD1119165S1) for a glove, with the patent assigned to HAND HELD PRODUCTS, INC. The patent was granted on March 24, 2026, based on a filing date of January 19, 2023.
USPTO Sleep Mask Design Patent Granted
The USPTO has granted a design patent (USD1120091S1) for a sleep mask, with an effective date of March 24, 2026. The patent was filed on May 28, 2024, by inventor Dongbin Qiu.
USPTO Grants Patent for Eye Drop Container
The USPTO has granted a design patent (USD1120304S1) for an eye drop container to ANY EYE LLC. The patent covers the ornamental design of the dispensing container, with inventors listed as Aram P. Najarian, Richard T. Najarian, and Andrew N. Seymour.
USPTO Patent Grant for Sanitary Napkin Design
The United States Patent and Trademark Office (USPTO) has granted Design Patent USD1120305S1 for a sanitary napkin design to The Procter & Gamble Company. The patent was granted on March 24, 2026, based on a filing date of April 30, 2024.
USPTO Grants Absorbent Article Patent to Procter & Gamble
The USPTO has granted a design patent (USD1120306S1) for an absorbent article to The Procter & Gamble Company. The patent covers the ornamental design of the article, with a filing date of March 7, 2025, and an issue date of March 24, 2026.
USPTO Patent Grant USD1120308S1 for GE Precision Healthcare
The USPTO has granted patent USD1120308S1 for a design related to prosthetics to GE Precision Healthcare LLC. The patent filing date was November 13, 2024, and the grant date is March 24, 2026. This is a design patent for a specific prosthetic device.
USPTO Grants Patent for Eye Protection for Micro Welding
The USPTO has granted a design patent (USD1120513S1) for eye protection specifically designed for micro welding applications. The patent, filed on September 4, 2024, lists Lyndi Love-Haning and Dustin Haning as inventors. This grant signifies a new design in protective equipment for specialized industrial tasks.
USPTO Patent Grant for Inclination Guide
The USPTO has granted a design patent (USD1120319S1) for an inclination guide. The patent was assigned to DePuy Ireland Unlimited Company and lists Simon John Faichen Davis as the inventor. The filing date was August 11, 2022.
USPTO Grants Patent for Medical Instrument for Eye Surgery
The USPTO has granted a design patent (USD1120323S1) for a medical instrument intended for eye surgical purposes. The patent was assigned to OERTLI-INSTRUMENTE AG and lists Katrin Blumenschein, Bernhard Schmidberger, Michael Zürcher, and Lisa Kehren-Quitsdorf as inventors. The filing date was January 17, 2025.
USPTO Grants Design Patent for Disc Prosthesis
The USPTO has granted a design patent (USD1120329S1) for a disc prosthesis to Greenwood Medical L.L.C. The patent covers the ornamental design of the prosthesis, with a filing date of December 18, 2024, and an effective date of March 24, 2026.
USPTO Patent Grant - Bandage Design USD1120349S1
The USPTO has granted a design patent (USD1120349S1) for a bandage design to Henan Beilite Auto Parts Co., Ltd. The patent was filed on February 11, 2025, and granted on March 24, 2026. This grant pertains to the aesthetic appearance of the bandage.
USPTO Thumb Brace Patent Grant USD1120351S1
The USPTO has granted a design patent (USD1120351S1) for a thumb brace to SHENZHEN WEPROTEX TECHNOLOGY PRODUCT CO., LTD. The patent, which includes one claim, was filed on December 9, 2024, and granted on March 24, 2026. This grant signifies the official recognition of the design's novelty and non-obviousness.
USPTO Design Patent Grant: Therapy Belt USD1120356S1
The USPTO has granted a design patent (USD1120356S1) for a therapy belt. The patent was assigned to HAIKOU LILI INVESTMENT CO., LTD. and lists Junyuan Chen as the inventor. The patent officially grants on March 24, 2026.
USPTO Patent Grant: Handheld palm cooling device
The USPTO has granted patent US12582547B2 for a handheld palm cooling device to Apex Cool Labs, Inc. The patent, granted on March 24, 2026, describes a device optimized for efficient heat transfer from fatigued muscles via direct contact with glabrous tissue.
USPTO Grants In Vivo Temperature Control System Patent
The USPTO has granted patent US12582548B2 for an in vivo temperature control system to Toray Industries, Inc. The patent describes a system using a catheter and temperature sensors to manage biological lumen temperature. This grant is a routine intellectual property event.
USPTO Patent Grants: Fluid Flow Rate in Phacoemulsification Probe
The USPTO has granted patent US12582550B2 to Johnson & Johnson Surgical Vision, Inc. for an apparatus determining fluid flow rate in a phacoemulsification probe. The patent details a method using pressure sensors and a processor to calculate flow rate, aiming to improve surgical procedures.
USPTO Patent US12582557B2: Bonding elastic parts under tension to carrier
The USPTO has granted patent US12582557B2 to The Procter & Gamble Company for a method and apparatus for bonding elastic parts under tension to a carrier substrate. This patent relates to the assembly of absorbent articles and was filed on September 10, 2024.
USPTO Grants Patent for Bi-directionally Positionable Tampon
The USPTO has granted a patent (US12582559B2) for a bi-directionally positionable tampon developed by Outasite, LLC. The patent, effective March 24, 2026, describes a tampon designed for improved positioning and absorption of vaginal discharge.
USPTO Grants Patent for Canine Diaper Assembly
The USPTO has granted a patent (US12582560B2) for a canine diaper assembly. The assembly includes a fluid-impermeable band with an integrated absorbent pad and a reactive strip that changes color upon contact with urine, providing a visual indicator.
USPTO Patent Grant: Absorbent Articles with Frangible Pathways
The USPTO has granted patent US12582561B2 to The Procter & Gamble Company for absorbent articles featuring frangible pathways designed for simultaneous tear propagation. This patent covers specific design elements for disposable absorbent products, such as diapers, aimed at improving their functionality.
USPTO Patent Grant: Absorbent Articles with Frangible Pathways
The USPTO has granted a patent (US12582562B2) to The Procter & Gamble Company for absorbent articles featuring frangible pathways. This patent covers specific designs for tear propagation between laminate regions with varying substrate layer counts, potentially impacting the manufacturing and design of such products.
USPTO Patent Grant: Welding Device with Haptic Sensing
The USPTO has granted a patent (US12582554B2) to 3M Innovative Properties Company for a welding protection device featuring haptic sensing. The patent, effective March 24, 2026, describes a device that can execute user-defined commands upon sensing a touch pattern.
USPTO Patent Grant: Reclosable underwear-type disposable article
The USPTO has granted patent US12582563B2 to ZUIKO CORPORATION for a reclosable underwear-type disposable article. The patent covers the design and manufacturing method for an article with flaps and touch fasteners that allow for re-engagement when worn.
USPTO Patent Grant: Self-extendable Pulmonary Artery Stent
The USPTO has granted patent US12582748B2 for a self-extendable pulmonary artery stent with a dry valve. The patent, assigned to P+F Products + Features GmbH, details a stent design with specific features for fixation and valve attachment, along with a delivery device.
USPTO Grants Patent for PTFE Coating Film on Stent
The USPTO has granted patent US12582512B2 to BCM CO., LTD. for a method of forming a PTFE coating film on a stent. The patent covers a method that can form the film regardless of stent shape, prevent peeling, and facilitate formation.
USPTO Grants Patent for Multifocal Intraocular Lens
The USPTO has granted a patent (US12582516B2) for a multifocal intraocular lens to HANITA LENSES LTD. The patent describes a lens with a diffractive surface featuring concentric rings and an asymmetrical distribution of energy flux.
USPTO Grants Patent for Prosthetic Heart Valve Sealing Member
The USPTO has granted a patent (US12582517B2) to Edwards Lifesciences Corporation for a sealing member designed to reduce perivalvular leakage in prosthetic heart valves. The patent, filed on April 13, 2021, details a sealing member with ribs and connectors intended to improve the performance and safety of prosthetic heart valves.
USPTO Grants Patent for Heart Valve Prosthesis with Variable Sealing Function
The USPTO has granted a patent (US12582518B2) to TRICARES SAS for a heart valve prosthesis featuring a variable sealing function. The patent covers the prosthesis itself, a method for its implantation, and its use in treating heart valve disorders. The filing date for this patent was May 25, 2020.
USPTO Patent Grant: Prosthetic Heart Valve Cuff (US12582519B2)
The USPTO has granted patent US12582519B2 to St. Jude Medical, LLC for a prosthetic heart valve cuff design. The patent, effective March 24, 2026, covers collapsible and re-expandable cuff designs for prosthetic heart valves.
USPTO Patent Grant for Implant Delivery System
The USPTO has granted patent US12582520B2 for an implant delivery system developed by 4C Medical Technologies, Inc. The patent covers apparatus and methods for delivering implants with constrained and relaxed configurations, including features like a strut, swivel body, pusher catheter, and force gauge.
US Patent Grant US12582521B2 for Prosthetic Heart Valve Delivery Device
The USPTO has granted US Patent US12582521B2 to Medtronic Vascular, Inc. for a delivery device for a prosthetic heart valve. The patent describes a device with a capsule adjustment mechanism designed for percutaneous delivery.
USPTO Patent Grant: Valve Repair Clip with Automatic Locking
The USPTO has granted patent US12582522B2 to Evalve, Inc. for a mitral valve repair clip with an automatic locking mechanism. The patent details a device designed to prevent movement of a stud relative to a lock by engaging the shank, with locking engagement only possible when a specific angle between arms is below a predefined threshold.
USPTO Patent Grant: Durability and Particulate Testing System
The USPTO has granted patent US12582523B1 for a durability and particulate testing system and method for medical devices. The patent, assigned to DYNATEK LABS, INC., details a system for simulating the expected lifetime of synthetic structural heart devices.
Heart Anchor Positioning Devices Patent Granted
The USPTO has granted a patent (US12582524B2) to BioVentrix, Inc. for heart anchor positioning devices, methods, and systems for treating congestive heart failure. The patent describes a device designed to engage and secure heart anchors to the heart wall, with a tension indicating mechanism.
USPTO Grants Implantable Mesh Patent to Warsaw Orthopedic, Inc.
The USPTO has granted patent US12582525B2 for an implantable mesh to Warsaw Orthopedic, Inc. The patent covers a mesh made from demineralized bone fibers mechanically entangled with non-bone fibers, intended for use at target bone tissue sites.
Medical Implant Device Patent Granted
The United States Patent and Trademark Office (USPTO) has granted patent US12582526B2 for a medical implant device to Statera Medical Inc. The patent covers systems and methods for evaluating a joint implant device, including specific mechanical components and their interactions.
USPTO Patent Grant for Triply Periodic Minimal Surface Implants
The USPTO has granted a patent to RESTOR3D, INC. for sheet-based triply periodic minimal surface (TPMS) implants designed to promote osseointegration. The patent covers novel gyroid architectures and selective laser melting techniques for improved mechanical performance and reduced defect formation in implants.
US Patent for Sacroiliac Joint Stabilization Systems
The USPTO has granted a new patent (US12582528B2) to Tenon Medical, Inc. for systems designed for minimally invasive sacroiliac joint stabilization. The patent covers specific instruments and assemblies for creating and fixating openings in the SI joint for prosthesis deployment.
US Patent US12582529B2 for Sacroiliac Joint Stabilization Prostheses
The USPTO has granted US Patent US12582529B2 for sacroiliac joint stabilization prostheses to Tenon Medical, Inc. The patent describes prostheses designed for press-fitting into pilot openings to stabilize dysfunctional sacroiliac joints, featuring a pontoon shape with porous sections.
USPTO Patent Grant US12582530B2 - Humeral Implant Component
The United States Patent and Trademark Office (USPTO) has granted patent US12582530B2 for a humeral implant component to WALDEMAR LINK GMBH & CO. KG. The patent, which includes an interface part for connecting components and a through hole for a fastener, was granted on March 24, 2026.
USPTO Patent Grant US12582531B2 for Shoulder Implant Systems
The USPTO has granted patent US12582531B2 to Arthrosurface Incorporated for novel humeral and glenoid articular surface implant systems and methods for shoulder repair. The patent details specific design features for glenoid implants and baseplates, including fixation elements and channels for assembly.
USPTO Grants Patent for Dual Mobility Cup Reverse Shoulder Prosthesis
The USPTO has granted a patent (US12582532B2) for a dual mobility cup reverse shoulder prosthesis, assigned to the University of Maryland, College Park. The patent covers a novel prosthesis system designed to improve shoulder joint function.
USPTO Patent Grant for Expandable Interbody Spacer
The USPTO has granted a patent (US12582533B2) for an integrated expandable interbody spacer designed for spinal fusion procedures. The patent was assigned to IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY and lists four inventors. The device allows for controlled adjustment of height during surgery.
USPTO Patent Grant US12582537B2 for Stent
The USPTO has granted patent US12582537B2 to Boston Scientific Scimed, Inc. for a stent with improved deployment characteristics. The patent details a knitted stent design with specific cell arrangements and loop/rung row configurations, including both open and closed cells.
USPTO Patent Grant US12582538B2 for Expandable Devices
The USPTO has granted patent US12582538B2 for expandable devices and associated systems and methods. The patent, assigned to The Foundry, LLC, details a stent configured to be expanded within a body conduit of a human patient.
USPTO Patent for Medical Device Crimper by Medtronic
The USPTO has granted a new patent (US12582539B2) to Medtronic for a clamshell iris-style crimper designed for medical devices. The patent details an innovative mechanism for compressing expandable medical devices, featuring a handle-operated clamshell design that reduces chamber volume to achieve compression.
USPTO Grants Patent for Intragastric Device
The USPTO has granted a patent for an intragastric device designed to restrict gastric capacity. The device, assigned to Servicio Cántabro De Salud Universidad De Cantabria, utilizes a neutral buoyancy principle with an inner core and an outer covering containing fluids at different pressures. This patent grant is a routine administrative action.
USPTO Grants Patent for Ankle Joint Mobilisation Apparatus
The USPTO has granted a patent (US12582543B2) to Azzurro Training Ltd for an apparatus designed to mobilise the human ankle joint. The patent details an apparatus with a base and strap, incorporating specific protrusions for medial arch support to enhance foot stability during dorsiflexion.
USPTO Grants Patent for Brace Hinge with Telescoping Pad
The USPTO has granted a patent (US12582544B2) for a brace hinge with a telescoping pad, assigned to DJO, LLC. The patent describes a hinge mechanism designed for braces, featuring adjustable force application and a novel adjustment assembly.
USPTO Patent Grant for Controlled Delivery Devices by Femasys Inc
The USPTO has granted patent US12582546B2 to Femasys Inc. for methods and devices for controlled delivery of material compositions, particularly occlusive, therapeutic, or diagnostic compositions. The patent was filed on August 21, 2023, and includes 16 claims.
USPTO Patent Grant: Pyridone Derivative Crystal Form
The USPTO has granted a patent to Jiangxi Caishi Pharmaceutical Technology Co., Ltd. for a novel pyridone derivative crystal form and its preparation method. This patent covers specific crystal forms and their application in treating influenza, potentially offering improved efficacy and bioavailability.
USPTO Patent US12583828B2: Aromatic Carbonyl Compounds Preparation Process
The USPTO has granted patent US12583828B2 to BASF SE for a process to prepare aromatic carbonyl compounds. The patent describes a catalytic oxidation method using molecular oxygen, a cobalt(II) salt, and N,N′,N″-trihydroxyisocyanuric acid (THICA).
USPTO Patent Grant: Process for Ethyleneamines and Ethanolamines Manufacture
The USPTO has granted patent US12583827B2 to BASF SE for a new process to manufacture ethyleneamines and ethanolamines. The patent details a two-step process involving the conversion of glycolaldehyde derivatives and an aminating agent, followed by hydrogenation.
USPTO Patent for Acetic Acid Derivatives as Safeners
The USPTO has granted a patent (US12583826B2) to Bayer Aktiengesellschaft for acetic acid derivatives and salts thereof, intended for use as safeners in crop protection compositions. These compounds aim to reduce the phytotoxic effects of agrochemicals, particularly herbicides.
Redona Therapeutics Cancer Treatment Compounds Patent Grant
The USPTO has granted Redona Therapeutics, Inc. a patent (US12583825B2) for novel cancer treatment compounds. The patent covers specific benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives and their use in treating neoplastic diseases.
USPTO Patent Grant: Benzylamine Derivative for Anti-Tumor Efficacy
The USPTO has granted a patent (US12583822B2) to the Academy of Military Medical Sciences for a benzylamine derivative with potential anti-tumor efficacy. The patent covers the derivative, its preparation method, and its use in treating PD-1/PD-L1-related diseases.
Omecamtiv Mecarbil Salt and Preparation Process
The USPTO has granted US Patent 12583821B2 to Cytokinetics, Inc. for a specific salt form of omecamtiv mecarbil and its preparation process. This patent covers the dihydrochloride salt form, related compositions, and methods of use, primarily impacting pharmaceutical development and intellectual property.
USPTO Patent US12583820B2: Antivirals against coronavirus
The USPTO has granted patent US12583820B2 to Kansas State University Research Foundation for broad spectrum antivirals against coronaviruses. The patent covers specific chemical compounds designed to inhibit viral replication.
Biomaterial with functionalized tyrosine, preparation method, pharmaceutical composition
The USPTO has granted a patent (US12583818B2) for a method to prepare a biomaterial with selectively functionalized tyrosine and a pharmaceutical composition containing it. This innovation aims to improve the efficacy of biomaterial drugs by ensuring selective coupling to tyrosine without affecting other amino acids or the biomaterial's inherent activity.
USPTO Patent Grant for Insomnia and Depression Compound
The USPTO has granted a patent (US12583841B2) to Breakthrough Pharmaceuticals Inc. for a tetrahydropyrrolocyclic compound and its application in preparing drugs to treat insomnia and depression by targeting the selective orexin-2 receptor. The patent was filed on January 27, 2022, and granted on March 24, 2026.
USPTO Patent Grant: Crystal Form of Nitroxoline Prodrug
The USPTO has granted patent US12583835B2 for a crystal form of a nitroxoline prodrug, a pharmaceutical composition containing it, and its preparation and application. The patent, assigned to Jiangsu Yahong Meditech Co., Ltd., describes crystal forms A and B with improved properties for industrial production and drug efficacy compared to nitroxoline.
USPTO Patent US12583838B2 for Kinase Inhibitors
The USPTO has granted patent US12583838B2 to Insilico Medicine Hong Kong Limited for kinase inhibitors designed for disease treatment. The patent covers specific compounds and their use in pharmaceutical compositions and methods for treating diseases.
USPTO Patent Grant US12583844B2: Hydantoin MMP Inhibitors
The USPTO has granted patent US12583844B2 to Foresee Pharmaceuticals USA, Inc. for hydantoin-based compounds that act as inhibitors of matrix metalloproteinases (MMPs), particularly MMP-12. The patent covers compositions and methods for treating various diseases mediated by MMP-12.
USPTO Patent Grant for Trinucleotide Repeat Disease Treatment
The USPTO has granted a patent (US12583845B2) to The Research Foundation for The State University of New York for compositions and methods to treat diseases involving trinucleotide repeats. The patent covers novel compounds and synthesis processes aimed at inhibiting microsatellite promoted expression of deleterious expansions.
USPTO Patent Grant: Benzopyran Derivatives as CRAC Inhibitors
The USPTO has granted a patent (US12583846B2) for benzopyran derivatives identified as CRAC inhibitors. The patent, filed on September 25, 2020, covers compounds represented by a specific formula, isomers, or pharmaceutically acceptable salts thereof, and their application in preparing CRAC inhibitors.
USPTO Patent Grant for Fluorinated Pyrimidine Compound Production
The USPTO has granted a patent (US12583847B2) to UNIMATEC CO., LTD. for a fluorinated pyrimidine compound and its production method. The patent covers specific chemical structures and synthesis processes, with a filing date of March 16, 2022.
USPTO Patent US12583848B2: Isoxazole Derivatives for Viral Infections
The USPTO has granted patent US12583848B2 to Universitätsklinikum Jena for isoxazole-3-carboxamide derivatives used in treating viral infections. The patent describes compounds effective against various viruses, including resistant strains, with low induction of cytochrome P4503A4.
USPTO Patent US12583849B2 for KCNT1 Inhibitors
The USPTO has granted patent US12583849B2 to PRAXIS PRECISION MEDICINES, INC. for KCNT1 inhibitors and methods of use. This patent covers compounds and compositions for treating neurological diseases, conditions related to excessive neuronal excitability, and gain-of-function mutations in genes like KCNT1.
USPTO Patent Grant: Pyrazine Derivatives for Pest Control
The USPTO has granted patent US12583851B2 to Elanco Animal Health GmbH for novel heteroaryl-substituted pyrazine derivatives. These compounds are intended for controlling animal pests, arthropods, insects in plant protection, and ectoparasites on animals.
USPTO Patent Grant: Heterocycle Derivative for Hair Loss Therapy
The USPTO has granted patent US12583852B2 for a novel heterocycle derivative, assigned to JW PHARMACEUTICAL CORPORATION. This patent covers compounds effective for the therapy and prevention of hair loss, including androgenic alopecia and alopecia areata.
USPTO Patent Grant for BCL-2 Inhibitors
The USPTO has granted a patent (US12583853B2) to Newave Pharmaceutical Inc. for 1H-pyrrolo[2,3-b]pyridine derivatives and related compounds as BCL-2 inhibitors. These compounds are intended for the treatment of neoplastic and autoimmune diseases.
Amgen KRAS G12C Inhibitors Patent Granted
The USPTO has granted Amgen Inc. a patent (US12583854B2) for KRAS G12C inhibitors and methods of using them to treat cancers. The patent covers compositions and methods for treating pancreatic, colorectal, and lung cancers.
USPTO Patent US12583857B2 for Anti-liferative Agents
The USPTO has granted patent US12583857B2 for anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines. The patent was granted to PHEON THERAPEUTICS LTD and covers compounds useful as medicaments, particularly as anti-proliferative agents.
Genentech, Inc. Granted Patent for TDO2 Inhibitors
The USPTO has granted Genentech, Inc. patent US12583858B2 for TDO2 inhibitors. These inhibitors are useful for modulating tryptophan 2,3 dioxygenase activity, treating immunosuppression, and enhancing anti-cancer treatments. The patent was filed on October 12, 2020.
USPTO Patent Grant for API Crystalline Form Preparation
The USPTO has granted patent US12583860B2 to Apotex Inc. for processes to prepare multicomponent crystalline forms of active pharmaceutical ingredients using solvent vapour. The patent covers methods involving mixing a solid API with a liquid or solid pharmaceutically acceptable entity in the presence of solvent vapour, utilizing standard rotary apparatus.
USPTO Grants Patent for Nanoporous Material for Ion Channels
The USPTO has granted a new patent (US12583863B2) to the University of Wyoming for a synthetically modifiable ion channel material. This material, a nanoporous structure with controlled electronic and ion transport properties, mimics natural zeolites and MOFs.
Organic EL Device with Different Host Materials
The USPTO has granted a patent for an organic electroluminescent (EL) device. The patent describes a device with two emitting layers, each containing a different host material and a compound that emits fluorescence with a main peak wavelength of 500 nm or less. The patent specifies a condition for the triplet energy of the host materials.
Biologically Active Taxane Analogs and Oral Treatment Methods - Patent Granted
The USPTO has granted a patent (US12583865B2) to Tapestry Pharmaceuticals, Inc. for biologically active taxane analogs and methods of oral treatment for cancer. The patent covers novel chemical compounds, compositions, manufacturing methods, and combinations with other therapeutic agents.
USPTO Patent Grant: IAP Antagonists for Cancer Treatment
The USPTO has granted a patent (US12583866B2) to BeOne Medicines I GmbH for novel pyrido[2,3-b][1,4]oxazine or tetrahydropyrido[2,3-b][1,4]oxazepine derivatives. These compounds act as antagonists of Inhibitors of Apoptosis Proteins (IAPs) and are intended for use in treating cancer by inducing or sensitizing cells to apoptotic cell death.
USPTO Patent Grant: Chemokine CXCR4 Receptor Modulators
The USPTO has granted a patent to Emory University for chemokine CXCR4 receptor modulators and their uses. The patent covers compounds and pharmaceutical compositions that can be used for managing various conditions including viral infections, abnormal cellular proliferation, and cancer.
USPTO Patent Grant: JAK Inhibitors Synthesis Methods
The USPTO has granted patent US12583868B2 for novel JAK inhibitors and methods for their synthesis and use, assigned to Galderma Holding SA. The patent covers compounds with formula (I) and their application in treating various diseases.
A2A Receptor Antagonist Salt and Crystal Forms
The USPTO has granted patent US12583869B2 for a salt form and crystal form of an adenosine A2A receptor antagonist, along with its preparation method. The patent, assigned to CSTONE PHARMACEUTICAL (SUZHOU) CO., LTD., also covers the application of these forms in preparing medicine for A2A receptor-related diseases.
USPTO Patent Grant US12583859B2 for PRMT5 Inhibitors
The USPTO has granted patent US12583859B2 to the California Institute of Technology for PRMT5 inhibitors. The patent covers compounds and methods useful in treating cancers and other diseases.
USPTO Patent Grant: PSMA Imaging Agents
The United States Patent and Trademark Office (USPTO) has granted patent US12583887B2 to Siemens Medical Solutions USA, Inc. for PSMA imaging agents. The patent covers compounds and methods for imaging prostate-specific membrane antigen (PSMA), suitable for PET and SPECT imaging.
Azaheteroaryl Compound Patent Granted
The USPTO has granted patent US12583870B2 to SHANGHAI BLUERAY BIOPHARMA CO., LTD. for an azaheteroaryl compound and its preparation method. This patent covers compounds and compositions for treating diseases related to EED protein and PRC2 protein complex mechanisms.
USPTO Grants PRMT5 Inhibitors Patent to Merck Sharp & Dohme
The USPTO has granted a new patent (US12583871B2) to Merck Sharp & Dohme LLC for PRMT5 inhibitors. The patent covers compounds and methods for treating conditions such as cancer, sickle cell, and hereditary persistence of foetal hemoglobin.
USPTO Patent Grant for PCSK9 Inhibitors
The USPTO has granted a patent (US12584120B2) to AstraZeneca AB for novel PCSK9 inhibitors and methods of use. The patent covers specific heteroaryl compounds that bind the PCSK9 protein, aiming to advance treatments for conditions related to cholesterol regulation.
USPTO Patent Grant: Light-Emitting Element with Long Lifetime
The USPTO has granted a patent (US12588408B2) to Semiconductor Energy Laboratory Co., Ltd. for a novel light-emitting element. The patent describes an element with a long lifetime and high efficiency, utilizing specific organic acceptor and host materials in its electron-transport layers.
USPTO Patent Grant: Daprodustat Crystal Form M Preparation and Use
The USPTO has granted patent US12583823B2 for a specific crystal form (crystal form M) of the drug daprodustat, a proline hydroxylase inhibitor. The patent covers the preparation method and use of this crystal form, which exhibits improved stability and solubility characteristics.
USPTO Patent Grant US12582652B2 for Ion Channel Modulator
The USPTO has granted patent US12582652B2 to Praxis Precision Medicines, Inc. for a novel ion channel modulator compound. The patent covers methods of treating neurological disorders and conditions associated with neuronal excitability.
USPTO Patent US12583840B2 for Androgen Receptor Antagonists Preparation
The USPTO has granted patent US12583840B2 to Orion Corporation for a method of preparing androgen receptor antagonists and their intermediates. The patent details a process using a heterogeneous palladium catalyst for the preparation of a specific benzonitrile compound useful in the synthesis of carboxamide-structured androgen receptor antagonists.
USPTO Patent Grant: PD-L1 Antagonist Compound
The USPTO has granted a patent (US12583839B2) to ADLAI NORTYE BIOPHARMA CO., LTD. for a PD-L1 antagonist compound and its pharmaceutical composition. The patent covers compounds of Formula (I) and their use in treating immune-related disorders.
USPTO Patent Grant: Bacterial Infection Treatment Compound
The USPTO has granted a patent (US12583834B2) for a compound and pharmaceutical composition designed to treat bacterial infections by inhibiting Mfd activity. The patent was filed on February 19, 2021, and is assigned to INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT.
USPTO Patent Grant: Diastereomer-Enriched Odorant Mixture Preparation
The USPTO has granted patent US12583833B2 to Symrise AG for a distillative process to prepare a diastereomer-enriched odorant mixture. The patent covers the process, the enriched mixture, and its use in perfumery to impart or enhance floral odor notes.
USPTO Patent Grant US12583831B2 for Hydrogenation Processes
The USPTO has granted patent US12583831B2 to Archer-Daniels-Midland Company for selective hydrogenation processes and catalysts. The patent covers methods for upgrading impure feedstocks, such as those derived from biomass, to increase the concentration of valuable intermediates like glycolaldehyde and hydroxyacetone.
USPTO Patent Grant: Oxetane Derivative Synthesis Method by Microreactor
The USPTO has granted a patent (US12583830B2) for a microreactor-based synthesis method for oxetane derivatives. The patent, assigned to Changzhou Tronly Advanced Electronic Materials Co., Ltd., details a process that improves efficiency, yield, and safety compared to traditional methods.
Missouri Agencies Alert Public to Rising Nitazene Threat
Missouri state agencies have issued a joint warning about the increasing presence of nitazenes, a potent synthetic opioid, detected in wastewater and illicit substances across the state. The alert urges public vigilance, prevention measures, and expanded access to naloxone, a life-saving overdose reversal medication.
HSA Seized Over 1 Million Illegal Health Products in 2025
Singapore's Health Sciences Authority (HSA) reported seizing over 1 million illegal health products in 2025, a 10% increase from the previous year. The agency also removed 2,358 online listings, a significant decrease from previous years due to increased surveillance and collaboration with platforms. The enforcement actions targeted cough syrups, sexual enhancement medicines, and sedatives.
WHO Recommends New Diagnostic Tools for Tuberculosis
The World Health Organization (WHO) has issued new guidelines recommending innovative diagnostic tools for tuberculosis (TB), including near-point-of-care tests and tongue swabs. These recommendations aim to accelerate diagnosis, reduce costs, and expand access to lifesaving services, particularly in resource-constrained settings.
FDA Extends Coral Snake Antivenin Expiration Date
The FDA has extended the expiration date for Lot CL6814 of Antivenin (Micrurus fulvius) (Equine Origin), commonly known as North American Coral Snake Antivenin, from June 30, 2025, to June 30, 2026. This extension is based on stability data indicating the lot will maintain potency for an additional year.
USPTO Patent Grant: Medical Device for Patient Inspection
The USPTO has granted patent US12582287B2 for a medical device designed for patient inspection and access. The device includes a base with an image capturing device and openings for direct patient inspection, assigned to JD Sanmed Medical Technology Pty Ltd.
USPTO Patent Grant: Grasping Cap for Over-the-Scope Applications
The USPTO has granted patent US12582292B2 for a grasping cap device designed for over-the-scope applications, assigned to Boston Scientific Scimed, Inc. The patent describes a device with an end cap and control members to facilitate tissue treatment applications via endoscopic scopes.
USPTO Patent US12582290B2: Optical Sensor Calibration for Composition Identification
The USPTO has granted patent US12582290B2 to Gyrus ACMI, Inc. for techniques related to optical sensor calibration for composition identification in medical procedures. This patent aims to improve the identification of anatomical targets during procedures like endoscopy and laparoscopy.
USPTO Grants Surgical Visualization Systems Patent to CAMPLEX, INC
The USPTO has granted a patent (US12582288B2) to CAMPLEX, INC. for surgical visualization systems. The patent covers devices with integrated cameras and methods for associating images from surgical tools with the main device's views, potentially improving surgical precision and reducing electromagnetic interference.
USPTO Surgical Instrument Lockout Features Patent Granted
The USPTO has granted patent US12582397B2 for a surgical instrument with lockout features, assigned to Cilag GmbH International. The patent describes a lockout assembly that prevents critical components from advancing until a surgical staple cartridge unlocks it.
Biomet Sports Medicine Patent US12582395B2 for Adjustable Loop
The USPTO has granted patent US12582395B2 to Biomet Sports Medicine, LLC for a method and apparatus for forming a self-locking adjustable loop. This patent covers a specific construct involving flexible members and passages designed for medical applications.
Olympus Medical Cartridge System Patent US12582406B2 Granted
The USPTO has granted patent US12582406B2 to Olympus Medical Systems Corp. for a cartridge system designed to store a clip unit, potentially for surgical applications. The patent details specific configurations for cartridge components and their relative movement.
Olympus Medical US Patent US12582405B2 for Cartridge System
The USPTO has granted US Patent US12582405B2 to Olympus Medical Systems Corp. for a cartridge system designed to store a clip unit. The patent details a specific configuration for the cartridge body and its storage areas to manage clip unit components and their connection to an applicator.
USPTO Patent Grant for Medical Device Detachment System
The USPTO has granted patent US12582404B2 to DePuy Synthes Products, Inc. for a medical device detachment system. The patent covers a method for manufacturing a system used for delivering implantable medical devices to target locations within the body.
USPTO Grants Patent for Vascular Malformation Treatment Device
The USPTO has granted a patent (US12582403B2) to ENDOSTREAM MEDICAL LTD. for a device designed to treat vascular malformations. The patent, filed on July 24, 2024, details an apparatus with specific orifice and docking sections for intravascular use.
USPTO Patent Grant for Implantable Sphincter Assistance Device
The USPTO has granted a patent (US12582402B2) for an implantable sphincter assistance device with a single-use emergency release mechanism. The patent was assigned to Cilag GmbH International and filed on December 16, 2021.
USPTO Patent Grant: Adapter assembly with constant velocity joints
The USPTO has granted patent US12582401B2 for an adapter assembly with constant velocity joints, assigned to Covidien LP. This patent covers a drive assembly for surgical devices, including specific shaft configurations for improved functionality.
USPTO Patent Granted for Endoscope Magnetic Navigation System
The USPTO has granted a patent (US12582400B2) to G.I. Windows, Inc. for an endoscope magnetic navigation system. The patent covers an end effector designed to secure magnetic anastomosis devices within a body lumen, allowing for the placement of small instruments through an endoscope's working channel.
USPTO Patent US12582398B2: Cartridge Status Detection
The USPTO has granted patent US12582398B2 to Intuitive Surgical Operations, Inc. for a method of detecting the status and presence of a surgical cartridge in an unfired condition within a surgical instrument. The patent details a system that commands movement of an actuation output and detects if the actuation amount meets a threshold, indicating the absence of a cartridge.
USPTO Grants Patent for Osteotomy Procedure
The USPTO has granted a new patent (US12582411B2) to Treace Medical Concepts, Inc. for an osteotomy procedure designed to correct bone misalignment, such as in bunion deformities. The patent details a method involving spherical bone cuts and multi-planar adjustments to correct anatomical alignment.
USPTO Surgical Sagittal Saw Cartridge Patent Granted
The USPTO has granted patent US12582410B2 for a surgical sagittal saw cartridge developed by Stryker European Operations Limited. The patent, granted on March 24, 2026, details a cartridge design featuring a guide bar and a blade with specific tooth configurations for surgical applications.
USPTO Patent Grant: Tissue Closure Method and Clip Device
The USPTO has granted patent US12582408B2 to Olympus Medical Systems Corp. for a tissue closure method and clip device. The patent details a method for grasping and closing tissue portions within the body using a specialized clip device.
USPTO Grants Patent for Surgical Bone Removal Tool
The USPTO has granted a patent (US12582415B2) to Medtronic PS Medical, Inc. for an oscillating surgical bone removal tool with a fluted cutting head. The patent describes a device with adjustable oscillation angles for controlled bone or tissue cutting.
USPTO Patent US12582414B2 for Bone Removal Devices
The USPTO has granted patent US12582414B2 to Wright Medical Technology, Inc. for devices and methods for removing bone, particularly in relation to implant removal. The patent describes a system including a rotating tool and a guide designed to facilitate precise bone removal adjacent to implants.
USPTO Grants Surgical Instrument Patent to BAK KOHLER MEDICAL KG
The United States Patent and Trademark Office (USPTO) has granted patent US12582413B2 for a surgical instrument to BAK KOHLER MEDICAL KG. The patent covers a surgical instrument designed for punching bones, featuring a unique cleaning mechanism.
USPTO Patent Grant: Surgical Instrument for Bone Cut Alignment
The USPTO has granted patent US12582412B2 to KICO KNEE INNOVATION COMPANY PTY. LTD. for a surgical instrument designed to align bone cuts during total joint replacement surgeries. The patent, effective March 24, 2026, details an instrument with a pivotable artificial articular surface to aid in coronal balancing and flexion alignment.
USPTO Patent Grant: Implantable Wireless Sensor for Bone Monitoring
The USPTO has granted a patent (US12582394B2) for an implantable wireless sensing device designed to monitor bone strain, load, and growth. The invention, assigned to the Arizona Board of Regents, aims to assist in predicting fractures and monitoring bone health in patients, particularly those with osteoporosis.
USPTO Grants Spinal Surgery Retractor Patent
The USPTO has granted a new patent (US12582393B2) for a spinal surgery retractor assembly and minimally invasive surgical techniques. The patent, filed in August 2022, was granted on March 24, 2026, to inventor Gary Fleischer.
USPTO Surgical Retractor System Joint Clamp Patent Grant
The USPTO has granted patent US12582392B2 for a surgical retractor system joint clamp to THOMPSON SURGICAL INSTRUMENTS, INC. The patent, filed on June 10, 2024, describes a clamp with a clip-on feature and springs to prevent rising movement.
USPTO Grants Patent for Intelligent Toothpaste Dispensing System
The USPTO has granted a patent to SHENZHEN BESMAN ELECTRONIC TECHNOLOGY CO., LTD for an intelligent toothpaste dispensing system. The system integrates a smart toothbrush, sensor, and dispenser to create custom toothpaste formulations based on user data.
USPTO Patent US12582238B2 for Sleep Recovery and Weight Loss
The USPTO has granted patent US12582238B2 to Sleep Solutions, Inc. for a system enhancing sleep recovery and promoting weight loss. The patent covers methods and articles, including machine learning, for stress reduction and sleep promotion.
ANSM Safety Information: Urology/Gynecology Suction Device
The French ANSM has been informed of a lot recall initiated by Clinical Innovations, LLC for their KIWI Omni Vacuum Delivery System suction device. This safety action is registered under number R2607844 and is directed at pharmacies and healthcare facilities.
ANSM Safety Alert: Manual Ventilator
The French ANSM has updated a safety alert regarding manual ventilators (Bavu) manufactured by Intersurgical. This update expands the scope of devices affected by a previous safety action initiated in May 2025, with users receiving updated correspondence.
ANSM Safety Alert: Kwik-Stik and Lyfo Disk Campylobacter jejuni Controls
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding bacteriology controls for Kwik-Stik and Lyfo Disk Campylobacter jejuni products from Microbiologics. This notice informs laboratories of a security action implemented by the manufacturer.
Dr. Angus J. Michaels Voluntary Practice Restrictions Agreement
The Massachusetts Board of Registration in Medicine and Dr. Angus J. Michaels have entered into a Voluntary Agreement for Practice Restrictions (VAPR). This agreement replaces a previous non-practice agreement and restricts Dr. Michaels' patient encounters to telehealth only, prohibiting in-person visits.
New Jersey Health Recognizes World Tuberculosis Day
The New Jersey Department of Health (NJDOH) issued a notice recognizing March 24 as World Tuberculosis Day. The notice highlights the ongoing impact of tuberculosis, provides statistics for New Jersey and globally, and reiterates the state's commitment to TB prevention and control efforts.
New Jersey Department of Health Recognizes World TB Day
The New Jersey Department of Health issued a notice recognizing March 24 as World TB Day. The notice highlights the ongoing efforts and impact of TB prevention and control in New Jersey, noting 342 new cases in 2024 and providing funding updates for local health departments.
DEA Omaha Seizes 70 Pounds of Methamphetamine
The DEA's Omaha Division announced the seizure of 70 pounds of methamphetamine. This action highlights ongoing efforts by law enforcement agencies to combat illicit drug trafficking.
DEA Memphis Arrests and Seizures
The DEA announced significant arrests and seizures in Memphis, Tennessee, including fentanyl, cocaine, meth, and numerous firearms. Administrator Cole provided remarks on the operation's success in combating drug trafficking and enhancing public safety.
DEA Phoenix Seizes 3 Million Fentanyl Pills in Arizona
The DEA Phoenix Division announced the seizure of nearly three million fentanyl pills in Arizona as part of Phase II of Operation FentanylFreeAmerica. This significant bust highlights ongoing efforts to combat the flow of illicit synthetic opioids.
USPTO Patent Grant for T Cell Antigen Receptor Complex
The USPTO has granted patent US12583910B2 to Tsinghua University for a T cell antigen receptor complex and its preparation method. This patent covers antibodies, T cell receptors, and immune cells designed to recognize pMHC complexes and activate T cells for therapeutic use.
USPTO Patent Grant: Antibody Inhibitors for Staphylococcus Aureus Treatment
The USPTO has granted patent US12583913B2 for antibody inhibitors targeting Staphylococcus aureus, specifically coagulases SC and vWbp. This patent covers therapeutic methods and detection techniques utilizing these monoclonal antibodies.
USPTO Patent Grant for Cancer Diagnosis using Anti-BAG2 Antibody
The USPTO has granted a patent (US12583915B2) to Medpacto, Inc. for methods of diagnosing cancer using an anti-BAG2 antibody. The patent covers compositions comprising antibodies that specifically bind to BAG2 polypeptides or fragments thereof.
USPTO Patent Grant for LRP6 Protein Binding Antibodies
The USPTO has granted a patent (US12583919B2) to Antlera Therapeutics Inc. for antibodies that specifically bind to LRP6 proteins and methods of their use. The patent was filed on August 14, 2020, and is set to be granted on March 24, 2026.
USPTO Patent Grant for Caged-Degron Molecular Feedback Circuits
The USPTO has granted patent US12583896B2 to The Regents of the University of California for caged-degron-based molecular feedback circuits. The patent covers methods of modulating signaling pathways in cells using these circuits, with a filing date of January 6, 2020.
USPTO Patent Grant: DNA-binding domain transactivators
The USPTO has granted a patent (US12583902B2) to the University of Massachusetts for DNA-binding domain transactivators and their uses. The patent covers recombinant adeno-associated viruses (rAAVs) designed to modify target gene expression in cells.
USPTO Patent Grant: Modified Plasma Clotting Factor VIII
The USPTO has granted patent US12583907B2 to AAVnerGene, INC. for modified human factor VIII polypeptides with enhanced activity. These polypeptides and their encoding viral vectors are intended for treating FVIII deficiencies, such as hemophilia A.
USPTO Patent US12583917B2: IL17A Antibodies for Veterinary Use
The USPTO has granted patent US12583917B2 to Elanco US Inc. for IL17A antibodies and antagonists intended for treating conditions in animals, including companion animals. The patent details specific antibody embodiments and IgG Fc variant polypeptides designed to reduce immune responses.
Mutant Myocilin Disease Model Patent Granted
The USPTO has granted Regeneron Pharmaceuticals, Inc. a patent (US12582104B2) for a mutant myocilin disease model. This patent covers non-human animal models engineered to express human myocilin, intended for assessing therapeutic reagents for glaucoma.
Amgen Inc. Patent for KRAS G12C Inhibitor Cancer Therapy
The USPTO has granted Amgen Inc. a patent (US12582657B2) for a combination therapy involving a KRAS G12C inhibitor and other agents for treating cancers. The patent covers pharmaceutical compositions and methods of treatment.
USPTO Patent Grant: RAS Oncoprotein Inhibitors
The USPTO has granted patent US12582660B2 to the University of Louisville Research Foundation, Inc. for inhibitors of the RAS oncoprotein, methods of making, and methods of use thereof. The patent covers compounds useful in treating diseases associated with activating mutations in RAS, particularly cancer.
USPTO Patent Granted for Anti-Pro/Latent Myostatin Antibodies
The USPTO has granted a patent (US12582712B2) to Scholar Rock, Inc. for a method of making anti-pro/latent myostatin antibodies. The patent covers antibodies that specifically bind proMyostatin and/or latent Myostatin and their uses.
USPTO Grants Patent for Anti-CD73 Antibody and Use
The United States Patent and Trademark Office (USPTO) has granted patent US12583933B2 to BIOTHEUS INC. for an anti-CD73 antibody and its use in enhancing immune response and treating tumors. The patent was filed on August 28, 2020, and is effective March 24, 2026.
USPTO Patent Grant for Tumor Diagnosis and Treatment
The USPTO has granted patent US12583937B2 to Genentech, Inc. for compositions and methods related to the diagnosis and treatment of tumors in mammals. The patent, filed on March 16, 2022, includes 6 claims.
Bi-specific Peptides for Cancer Treatment Granted Patent
The USPTO has granted a patent (US12583888B2) to the University of Tartu for bi-specific peptides designed to target cancer cells and the extracellular matrix. These peptides bind to fibronectin extra domain B (FN-EDB) and/or tenascin-C C domain (TNC-C). The patent was granted on March 24, 2026.
USPTO Patent Grant for Peptides Treating Type 1 Diabetes
The USPTO has granted patent US12583891B2 to PHOENIX ALPHA for peptides and methods used in the treatment of type 1 diabetes. The patent covers specific peptide sequences and their application in generating cytolytic CD4+ T cells.
USPTO Patent Grant US12583892B2: Conus Peptides for Neurodegenerative Conditions
The USPTO has granted patent US12583892B2 to Technion Research and Development Foundation Limited for modified Conantokin peptides and their use in treating neurodegenerative conditions. The patent covers specific peptide forms, nucleic acids encoding them, and compositions for modulating NMDA receptors.
USPTO Grants Patent for ACE Inhibitor and Blood Pressure-Lowering Agent
The USPTO has granted a patent (US12582146B2) to MARUZEN PHARMACEUTICALS CO., LTD. for an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent containing a specific compound. The patent also covers beverages and food products incorporating this compound.
USPTO Patent Grant: Topical Anti-inflammatory Composition with Zileuton
The USPTO has granted a patent (US12582598B2) to QURIENT CO., LTD. for a topical anti-inflammatory pharmaceutical composition comprising Zileuton. The patent covers the composition, its uses, and methods of preparation.
USPTO Patent Grant: B-RAF Kinase Inhibitor Solid Dispersion
The USPTO has granted a patent to BeiGene, Ltd. for a stable solid dispersion of a B-RAF kinase dimer inhibitor, Compound 1. The patent covers the composition, methods of preparation, and uses of this solid dispersion, as well as a crystalline form of Compound 1.
USPTO Patent Grant: Theranostic Agents for PSMA Positive Cancers
The USPTO has granted a patent (US12582728B2) to Memorial Sloan Kettering Cancer Center for theranostic agents targeting PSMA positive cancers. The patent covers compositions and methods for detecting and treating cancer using novel radiohalogenated PSMA targeting agents for diagnostic imaging and radiation therapy.
Bifunctional compounds for degrading BTK via ubiquitin pathway
The USPTO has granted patent US12582722B2 to Nurix Therapeutics, Inc. for bifunctional compounds designed to degrade Bruton's tyrosine kinase (BTK) through the ubiquitin proteolytic pathway. The patent covers novel compounds and pharmaceutical compositions for treating various diseases.
USPTO Grants Patent for Bis-biguanide Compounds in Cancer Management
The USPTO has granted a patent (US12582618B2) to Emory University for bis-biguanide compounds and pharmaceutical compositions for managing cancer, particularly lung cancer. The patent covers methods of treatment and related compositions, with an effective grant date of March 24, 2026.
USPTO Patent Granted for Dissociative Disorder Treatment Methods
The USPTO has granted a patent (US12582616B2) to The Board of Trustees of the Leland Stanford Junior University for methods of treating dissociative disorders. The patent covers agents that modulate neural activity in the posteromedial cortex to treat these conditions.
Patent: ROS-detonable Nanoclusters for Anti-Restenotic Therapy
The USPTO has granted a patent (US12582613B2) for biomimetic, reactive oxygen species-detonable nanoclusters designed for anti-restenotic therapy. The technology, assigned to the University of Virginia Patent Foundation, involves nanoclusters with self-assembled cores and biomimetic membrane coatings that can deliver anti-restenotic drugs.
Moderna Cancer Vaccines Patent Grant
The USPTO has granted patent US12582609B2 to ModernaTX, Inc. for cancer ribonucleic acid (RNA) vaccines. The patent covers cancer RNA vaccines, methods of use, and compositions. This grant is a routine notification of intellectual property protection.
USPTO Patent Grant: Kit for Producing and Storing Radiopharmaceuticals
The USPTO has granted patent US12582729B2 to Wake Forest University Health Sciences for a kit technology designed for the production and long-term storage of Zr-89-PET radiopharmaceuticals. The patent covers improved stability for radiopharmaceuticals and a method for their production.
NCDHHS and PRN Groundbreaking for New Respite Center
The North Carolina Department of Health and Human Services (NCDHHS) announced a groundbreaking event for a new respite center in Cabarrus County, funded with nearly $1 million from NCDHHS. The center, operated by Promise Resource Network (PRN), will provide a peaceful space for residents to manage their mental health.
Pennsylvania Invests $6M for Free Student Period Products, Proposes $3M More
The Shapiro Administration has invested $6 million over two years to provide free period products in Pennsylvania schools and has proposed an additional $3 million for the 2026-27 budget. This initiative aims to improve health equity and keep students in the classroom by addressing the affordability and accessibility of essential hygiene products.
HHS Adopts Standards for Health Care Claims Attachments and Electronic Signatures
The Department of Health and Human Services (HHS) has finalized standards for health care claims attachments transactions and electronic signatures. This rule aims to streamline administrative processes within the healthcare industry by adopting new standards for these transactions.
Andrew Merdinyan - Pharmacy Technician License Surrender
The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Andrew Merdinyan's pharmacy technician license (PhT-131188) due to allegations of controlled drug diversion. Merdinyan allegedly diverted approximately 1,236 tablets/capsules from a Walgreens pharmacy.
Walmart Pharmacy Disciplinary Final Order
The New Hampshire Board of Pharmacy issued a disciplinary final order against Walmart Pharmacy concerning multiple locations. The order details the procedures and timelines for filing petitions for rehearing and the right to appeal the decision to the New Hampshire Supreme Court.
Felicia Dern - Voluntary Surrender of Pharmacy Tech License
The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Felicia Dern's Registered Pharmacy Technician license (PHT-130661). This action follows allegations of drug diversion and substance misuse disorder, which led to her termination from Rite Aid.
NH Board of Pharmacy - Emergency Suspension of Pharmacist License
The New Hampshire Board of Pharmacy has issued an emergency order suspending the license of pharmacist Justin Eric Lachance. The suspension follows findings of suspected diversion of controlled substances, including Clonazepam and Zolpidem, observed via Walgreens surveillance and confessed by the licensee.
Andrew Merdinyan License Emergency Suspension Order
The New Hampshire Board of Pharmacy has issued an emergency suspension order for the license of Andrew Merdinyan, a Registered Pharmacy Technician. The suspension is due to findings of probable cause that the licensee engaged in conduct posing an imminent danger to public health, safety, and welfare, including admitting to taking controlled medications from a pharmacy.
Georgia Pharmacy Board Actions - January 2026
The Georgia Board of Pharmacy has issued its January 2026 Public Board Actions List. This list details enforcement actions taken against licensees, including the summary suspension of a facility's license and the lifting of a pharmacist's suspension. Specific licensee names and license numbers are provided for each action.
Georgia Pharmacy Board Actions - February 2026
The Georgia Board of Pharmacy has issued a list of actions taken in February 2026. These actions include a voluntary surrender for a technician and a consent order for a facility, Xttrium Laboratories, Inc. Specific details on the nature of the consent order and surrender are pending further documentation.
GA Board of Pharmacy Actions - January 2025
The Georgia Board of Pharmacy has revoked the registration of Yental Breanna Alford (PHTC051190) in its January 2025 public actions list. This action pertains to a pharmacy technician.
GA Board of Pharmacy Actions - February 2025
The Georgia Board of Pharmacy has issued a list of actions taken in February 2025. These actions include a voluntary cease and desist order for Steri-Tek PHWH004241 and a consent order for S2 Medical Supply, LLC (PHDME000685). Specific details on the nature of violations or penalties are not provided in this summary.
Georgia Board of Pharmacy Consent Orders and Revoked Registrations
The Georgia Board of Pharmacy has issued consent orders for Musely Compounding Pharmacy East LLC and Cornerstone Medical, Inc. Additionally, registrations for technicians Amira Jayde Brooks and Cythnia Elaine Brannon have been revoked.
NIH Loan Repayment Programs OMB Review Comment Request
The National Institutes of Health (NIH) has submitted a request for Office of Management and Budget (OMB) review regarding its Loan Repayment Programs. This notice is a 30-day comment request, allowing interested parties to provide feedback on the information collection associated with these programs.
NIH Strategic Plan Framework FY2027-2031 Request for Comments
The National Institutes of Health (NIH) is seeking public comments on a framework for its agency-wide strategic plan for Fiscal Years 2027-2031. This Request for Information (RFI) aims to gather input to shape the NIH's future research priorities and initiatives.
NIH Office of the Director Charter Renewal Notice
The National Institutes of Health (NIH) has published a notice in the Federal Register regarding the renewal of the charter for its Office of the Director. This notice serves to inform the public about the continuation of this advisory committee.
Center for Scientific Review Closed Meetings Notice
The National Institutes of Health (NIH) published a notice regarding upcoming closed meetings for the Center for Scientific Review. These meetings are part of the standard review process for grant applications and do not involve new regulatory requirements.
National Institute on Deafness and Other Communication Disorders Notice of Closed Meetings
The National Institutes of Health (NIH) has issued a notice regarding upcoming closed meetings for the National Institute on Deafness and Other Communication Disorders. These meetings are scheduled for April 27, 2026. The notice provides details on the dates of these sessions.
Spirulina Extract Color Additive Effective Date Delayed
The FDA has delayed the effective date of its final order regarding spirulina extract as a color additive. The original effective date of February 6, 2026, is now indefinitely postponed, with a new effective date to be announced via a future Federal Register publication.
FDA Delays Effective Date for Beetroot Red Color Additive
The Food and Drug Administration (FDA) has delayed the effective date for the final order concerning the color additive Beetroot Red. The original effective date of February 6, 2026, is now indefinitely postponed, with the FDA to announce a new effective date or further administrative action via a future Federal Register notice.
FDA Completeness Assessment Correspondence
The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice indicates that specific correspondence documents are available for review, authored by CDER.
FDA Complaint Document
The FDA has posted a complaint document related to its regulatory activities. The document is available for review via the provided URL, with an attachment labeled 'Complaint' authored by CTP.
FDA Completeness Assessment Correspondence
The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice provides information from the Center for Drug Evaluation and Research (CDER) regarding the completeness of submitted applications.
FDA CDER Final Response Letter to Rising Pharma Holdings
The FDA's Center for Drug Evaluation and Research (CDER) has issued a final response letter to Rising Pharma Holdings, Inc. The document details the agency's final decision regarding the company's submission. Specific details of the response are contained within the letter.
FDA Announces Public Hearing on CNPV Pilot Program
The FDA is announcing a public hearing on its Commissioner's National Priority Voucher (CNPV) Pilot Program, designed to expedite review times for qualifying new drug applications and biologics license applications. The agency is seeking feedback on program eligibility, selection processes, and review procedures.
FDA Complaint Document
The FDA has posted a complaint document related to its Center for Tobacco Products (CTP). The document was made available for public comment on March 23, 2026.
FDA Complaint Document
The FDA has posted a complaint document authored by CTP. The document is available for download via a link provided on the Regs.gov portal. No further details on the complaint's content or its regulatory implications are provided.
FDA Complaint Filed and Closed for Comments
The FDA has filed a complaint related to tobacco products, which is now open for public comment. The complaint was filed on March 23, 2026, and the comment period is active.
FDA Complaint Document
The FDA has posted a complaint document related to its Center for Tobacco Products (CTP). The document is available for review on Regulations.gov, though no specific details about the complaint's content are provided in the metadata.
FDA Complaint Received
The FDA received a complaint on March 23, 2026, related to tobacco products. The complaint document is available for review, though no specific details or actions are provided within the metadata.
FDA Complaint Filed
The FDA has filed a complaint on March 23, 2026, related to tobacco product regulation. The complaint was authored by the Center for Tobacco Products (CTP). Further details on the specific allegations and parties involved are expected to be available.
FDA Complaint Filed and Closed for Comments
The FDA has filed a complaint related to tobacco products, which is now open for public comment. The complaint was filed on March 23, 2026, and the comment period is ongoing.
FDA Complaint Filed and Closed for Comments
The FDA has filed a complaint related to pharmaceutical products, which has now been closed for public comment. The complaint was authored by CTP and is available for review on regulations.gov.
FDA Complaint Document Details
The Food and Drug Administration (FDA) has posted a complaint document related to its regulatory activities. The document is available for review, and the comment period for this specific item has closed.
FDA Complaint Posted
The FDA has posted a complaint related to tobacco products, authored by CTP. The document was made available on March 23, 2026, and the comment period has closed.
FDA Complaint Document
The FDA has posted a complaint document related to tobacco product regulations, authored by the Center for Tobacco Products (CTP). This document is open for public comment until March 23, 2026.
FDA Complaint Document
The FDA has posted a complaint document related to its regulatory activities. The document is available for review on the Regulations.gov portal. No specific compliance actions or deadlines are indicated for regulated entities.
FDA CDER Final Response Letter to AdventaPharma DWC-LLC
The FDA's Center for Drug Evaluation and Research (CDER) has issued a final response letter to AdventaPharma DWC-LLC. This document is part of the ongoing regulatory process for drug applications and does not appear to contain new compliance obligations.
FDA Completeness Assessment Correspondence
The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice indicates that documents are available for review concerning the completeness of certain regulatory submissions.
FDA CDER Response Letter to Laboflex, Inc.
The FDA's Center for Drug Evaluation and Research (CDER) has issued a response letter to Laboflex, Inc. The document is a final response, indicating a resolution or specific feedback on a matter concerning the company. No further details on the content or specific regulatory actions are available.
Animal Drug User Fees Reporting - Comment Period
The FDA is seeking public comment on proposed information collection provisions related to its animal drug and animal generic drug user fee programs. The comment period is open until May 22, 2026, as required by the Paperwork Reduction Act.
FDA Complaint Document Posted for Comments
The FDA has posted a complaint document related to tobacco products for public comment. The document is available for review and submission of feedback.
FDA Complaint Document
The FDA has posted a complaint document related to tobacco regulation, authored by CTP. This document is part of a public consultation process, with a comment period that has now closed.
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request
The Health Resources and Services Administration (HRSA) is requesting public comment on its plan to submit an information collection request to the Office of Management and Budget (OMB) for review and approval. This pertains to the Bureau of Health Workforce Performance Data Collection, OMB No. 0906-0086.
HRSA Rural Health Care Coordination Program Performance Measures
The Health Resources and Services Administration (HRSA) is proposing new performance measures for the Rural Health Care Coordination Program. This notice requests public comment on the proposed information collection activities, including the title of the collection and the associated OMB control number.
CDC Proposed Data Collection for Public Comment
The Centers for Disease Control and Prevention (CDC) has submitted a proposed data collection for public comment. The comment period is open for 63 days, closing on May 26, 2026. This action allows the public to provide input on the proposed data collection initiative.
CDC: Nominations Sought for Mine Safety Research Advisory Committee
The Centers for Disease Control and Prevention (CDC) is seeking nominations for individuals to serve on the Mine Safety and Health Research Advisory Committee. The notice outlines the nomination process and the deadline for submissions.
Proposed Data Collection for Public Comment
The Centers for Disease Control and Prevention (CDC) has submitted a proposed data collection for public comment. This notice provides instructions and deadlines for submitting feedback on the proposed data collection initiative.
CDC Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has published a notice in the Federal Register regarding agency forms undergoing Paperwork Reduction Act (PRA) review. This notice informs the public about the forms that are subject to PRA review, which is a process to ensure federal agencies do not collect information from the public without appropriate justification and OMB approval.
South Carolina Health Planning Committee Meeting Announcement
The South Carolina Health Planning Committee announced it will hold a meeting on Wednesday, March 25, 2026, at 1 p.m. The meeting will take place at the State of South Carolina Health Campus and will also be available virtually. The agenda and virtual viewing link are posted on the meeting event page.
Hearing Aid Specialists Committee Meeting Notice
The South Carolina Department of Health has announced that the Commission of Hearing Aid Specialists Committee will hold a meeting on March 25, 2026, at 10 a.m. The meeting will take place at the State of South Carolina Health Campus in Cayce, SC. Information regarding the agenda and virtual viewing options is available on the meeting event page.
South Carolina Health Ranking Improvement
The South Carolina Department of Health and Environmental Control (DPH) announced an improvement in the state's health ranking to 36th in the United Health Foundation's 2025 Annual Report. This marks the state's highest ranking since the report's inception in 1990, attributed to factors like increased cancer screenings and decreased physical inactivity.
Michigan Launches New Sickle Cell Disease Strategic Plan
The Michigan Department of Health and Human Services has released a new strategic plan for 2026-2030 to improve care and services for individuals with sickle cell disease (SCD). The plan focuses on reducing barriers to care for adults and builds upon previous initiatives, incorporating community input to expand access and strengthen public health surveillance.
Boil Water Advisory for Thayer, Neosho County
The Kansas Department of Health and Environment (KDHE) has issued a boil water advisory for the City of Thayer public water supply system due to a waterline break causing a loss of pressure. Customers are advised to boil water for one minute before drinking or food preparation until further notice.
JETA Intent to Use Trademark for Beverages and Apparel
The USPTO has received an intent-to-use trademark application from JETA for various goods including empty bottles, drinkware, apparel, and nutritional supplements. The application covers products such as shaker bottles, scoops, frothers, activewear, headwear, socks, footwear, sports drinks, meal replacements, and various supplements.
USPTO Trademark Application for TARGETED SCIENCE
The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for the mark "TARGETED SCIENCE". The application covers various types of supplements, including vitamin, dietary, and nutritional supplements, particularly those for prostate health.
USPTO Trademark Publication: VIRIFLOW for Supplements
The USPTO has published the trademark application VIRIFLOW for dietary and nutritional supplements. The application was filed on November 19, 2025, and published for opposition on March 22, 2026. This publication marks a step in the trademark registration process.
PAWGUS intent to use trademark application filed Mar 22, 2026
PAWGUS intent to use trademark application filed Mar 22, 2026
Centurion Health Trademark Published for Opposition
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'Centurion Health' for opposition. The application covers a range of pharmaceutical products, including allergy medication, cough syrups, dietary supplements, and pain relief medication.
Hyvia Health Intent to Use Trademark for Herbal Supplements
The USPTO has received an intent-to-use trademark application (TM99100449) from Hyvia Health for herbal supplements. The application covers products intended for longevity, memory, and mental health and clarity.
LITIMIC Trademark Status Change
The USPTO has recorded a status change for the LITIMIC trademark application (TM99165165), which covers various pharmaceutical preparations. The status change is noted with an effective date of March 22, 2026.
LHOPEBK NATURE Trademark Registration
The USPTO has registered the trademark LHOPEBK NATURE for a variety of dietary supplements, including alginate, casein, enzyme, glucose, lecithin, mineral, pollen, propolis, protein, royal jelly, whey protein, and yeast supplements. The registration was finalized on March 22, 2026, following a filing date of June 11, 2024.
USPTO Trademark Application for Pain Management
The USPTO has published a trademark application for "CUSTOM INTERVENTIONAL PAIN MANAGEMENT" for use with local anesthetics and customized medical kits. The application was published for opposition on March 22, 2026, with a filing date of September 24, 2024.
USPTO Trademark Application: COMPRESSION ASSIST
The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for the mark 'COMPRESSION ASSIST'. The application covers personal lubricants and therapeutic sprays for muscle relaxation. The filing date was November 12, 2024.
MACRO VITAL USPTO Trademark Application
The USPTO has received an intent-to-use trademark application for the mark 'MACRO VITAL'. The application covers a wide range of dietary and nutritional supplements, including drink mixes, enzyme supplements, protein shakes, and vitamin supplements. The filing date for this application was November 29, 2024.
USPTO Trademark Publication: Collagen Bio-Peptides Protein
The USPTO has published the trademark application for 'Collagen Bio-Peptides Protein' for nutritional supplements. The application was filed on August 5, 2025, and published for opposition on March 22, 2026.
Green Monkey Trademark Application Published
The USPTO has published the Green Monkey trademark application for herbal supplements for opposition. The application was filed on July 29, 2025, and published on March 22, 2026. This publication initiates a period during which third parties may oppose the trademark registration.
USPTO Intent to Use Trademark Application for Runner Bar
The USPTO has received an intent-to-use trademark application for the mark 'Runner Bar' for various nutritional supplement bars. The application was filed on August 6, 2025, and is designated for use with products aimed at boosting energy and supporting endurance for athletes.
SUNTROVE Trademark Renewal for Medical Supplies
The USPTO has renewed the SUNTROVE trademark (TM99324375) for a range of medical supplies and supplements. The renewal is effective March 22, 2026, and was filed on August 6, 2025. This action pertains to goods including bandages, disinfectants, vitamins, and dietary supplements.
SUNIGHT Trademark Renewal
The USPTO has renewed the SUNIGHT trademark (TM99328696) for various pharmaceutical and health-related products. The renewal is effective March 22, 2026, and covers items such as sanitary towels, vitamins, health food supplements, and medicinal dressings.
USPTO Trademark Application: JUST DENTAL LAB
The USPTO has received an intent-to-use trademark application for 'JUST DENTAL LAB' filed on December 8, 2024. The application covers services related to custom dental prosthetics, dentures, and orthodontic retainers.
Zerenne Trademark Registered for Dietary Supplements
The USPTO has registered the trademark ZERENNE (TM98895104) for use in connection with dietary supplements, natural sleep aid preparations, and nutritional supplements in gummy form. The trademark was registered on March 22, 2026, following a filing date of December 10, 2024.
USPTO Intent to Use Trademark Application: Velvet Hammer
The USPTO has received an intent to use trademark application for 'Velvet Hammer' filed on May 23, 2025. The application covers a powdered nutritional supplement drink mix and concentrate. This filing initiates the trademark registration process for the applicant.
OPTI + AREDS 2 Trademark Application
The USPTO has received an intent-to-use trademark application for 'OPTI + AREDS 2' filed on May 24, 2025. The application covers dietary and nutritional supplements for eye health.
ONEKEEP Trademark Registration
The USPTO has registered the trademark "ONEKEEP" for a range of pharmaceutical and health-related products, including nursing pads, herbal products, antimicrobial preparations, and dietary supplements. The registration was finalized on March 22, 2026, following a filing date of June 10, 2025.
USPTO Intent to Use Trademark Application - HY5
The USPTO has received an intent-to-use trademark application (TM99240025) for the mark 'HY5'. The application, filed on June 18, 2025, covers nutritional supplements and electrolyte replacement solutions.
MINICOO Trademark Application for Vitamin Supplements
The USPTO has received an intent-to-use trademark application for the mark "MINICOO" filed on July 4, 2025. The application covers a range of products including vitamin supplements, protein dietary supplements, and nutraceuticals for human and animal use.
ECTODOL Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'ECTODOL' (TM99273970) for pharmaceutical products. The renewal is effective until March 22, 2026.
METHL Trademark Registration - Vitamins
The USPTO has registered the trademark METHL for vitamins, filed on July 9, 2025, and officially registered on March 22, 2026. This registration pertains to intellectual property rights for a product within Class 005.
USPTO Intent to Use Trademark Application for ZING
The USPTO has received an intent-to-use trademark application for the mark 'ZING' for use with medicated lozenges and non-medicated functional beverages. The application was filed on July 10, 2025, with an effective date of March 22, 2026.
Phazebreak Trademark Application for Protective Coatings
The USPTO has received an intent-to-use trademark application for the mark 'PHAZEBREAK'. The application covers a wide range of protective coatings and related services for industries including aerospace, wind turbines, and solar panels. This filing indicates a potential new market entrant or product line in specialized coating technologies.
USPTO Intent to Use Trademark Application for Protein Bars
The USPTO has received an intent-to-use trademark application for 'Adam's Bar', intended for protein supplements formed and packaged as bars. The application was filed on August 29, 2025, with an expected use date of March 22, 2026.
GOMAVU Trademark Application Published for Opposition
The USPTO has published the GOMAVU trademark application for opposition. The application, filed on September 16, 2025, covers products such as toilet deodorants and deodorizers. The publication date for opposition is March 22, 2026.
New You Pretty Sparkling Trademark Application Filed
The USPTO has received a new trademark application for 'New You Pretty Sparkling' filed by an unspecified entity. The application covers non-alcoholic carbonated beverages, carbonated waters, fruit-flavored beverages, sparkling water, and various dietary and nutritional supplements.
New You Pretty Energy Trademark Application
The United States Patent and Trademark Office (USPTO) has received a new trademark application for 'NEW YOU PRETTY ENERGY' filed on October 8, 2025. The application is for intent to use and covers various energy drinks, dietary supplements, and related products.
USPTO Trademark Application for Probelle
The USPTO has received an intent-to-use trademark application for the mark "Probelle" filed on October 28, 2025. The application covers goods including dietary supplements, nutritional supplements, and herbal supplements.
PINAINICE Trademark Publication
The USPTO has published the trademark application for PINAINICE, covering various medicated skin care preparations and pharmaceutical substances. The application was filed on October 29, 2025, and published for opposition on March 22, 2026.
YOYOFOX Trademark Application Published for Opposition
The USPTO has published the YOYOFOX trademark application for opposition, covering self-adhesive dressings, elastic bandages, and hydrogel for medical purposes. The application was filed on October 21, 2025, and published on March 22, 2026.
USPTO Trademark Application - Equine Products Ireland
The USPTO has received an intent-to-use trademark application from Equine Products Ireland for vitamins and dietary food supplements for animals. The application was filed on October 30, 2025.
NUMIATE Trademark Intent to Use Application
The USPTO has received an intent to use trademark application for "NUMIATE" (TM99477578) filed on November 4, 2025. The application covers medicated and non-medicated skin care preparations. This filing indicates a future intention to use the mark in commerce.
USPTO Trademark Publication: THE DAILY 4
The USPTO has published the trademark application for 'THE DAILY 4' for opposition. The application covers dietary and nutritional supplements, vitamin and mineral supplements, and online ordering services for these products. The filing date was November 4, 2025.
USPTO Trademark Application for Honest Dose Supplements
The USPTO has received an intent-to-use trademark application for 'Honest Dose' for various supplements, including probiotic, vitamin, mineral, and herbal supplements. The application was filed on November 4, 2025, with an intended use date of March 22, 2026.
Navy St. Trademark Application - Intent to Use
The USPTO has received an intent-to-use trademark application for the mark 'NAVY ST.' filed on November 11, 2025. The application covers a range of pharmaceutical and cosmetic products, including acne treatments, medicated cosmetics, sunscreens, moisturizers, and hair care products.
USPTO Trademark Application - Metabolic Hydration
The USPTO has received an intent-to-use trademark application for 'METABOLIC HYDRATION' for a powdered nutritional supplement drink mix. The application was filed on November 12, 2025, with an intended use date of March 22, 2026.
MAEVA Intent to Use Trademark Application for Supplements
The USPTO has received an intent-to-use trademark application (TM99492340) for the mark 'MAEVA'. The application covers powdered supplement drink mixes, protein powders, and other nutritional powders for human consumption. The filing date for this application was November 12, 2025.
USPTO Trademark Application Published for Opposition: TOP-Q
The USPTO has published the trademark application for 'TOP-Q' for opposition, covering various pharmaceutical and medical products. The application was filed on November 12, 2025, and the publication date for opposition is March 22, 2026.
USPTO Trademark Application Published for Opposition
The USPTO has published trademark application TM99492217 for opposition. The application covers a wide range of cosmetic and beverage products, including skin moisturizers, creams, sports drinks, and dietary supplements. The filing date for this application was November 12, 2025.
USPTO Trademark Application for Cosmetics and Supplements
The USPTO has received an intent-to-use trademark application (TM99492231) for various cosmetic and dietary supplement products. The application was filed on November 12, 2025, with an intended use date of March 22, 2026.
USPTO Trademark Application for Hypawthesis
The USPTO has received an intent-to-use trademark application for the mark 'HYPAWTHESIS' for dietary supplements for dogs. The application was filed on November 12, 2025, with an intended effective date of March 22, 2026.
THERAZURE Trademark Application Published for Opposition
The United States Patent and Trademark Office (USPTO) has published the trademark application for THERAZURE for opposition. The application covers veterinary preparations for treating thrush and other hoof ailments in equines and other hooved animals. The publication date is March 22, 2026.
ADY Trademark Application Published for Opposition
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'ADY' for opposition. The application covers a wide range of beverages, food supplements, and related products. The publication date for opposition is March 22, 2026.
Omega 3 Basix Trademark Published for Opposition
The USPTO has published the trademark application for 'Omega 3 Basix' for opposition, with a publication date of March 22, 2026. The application covers dietary and nutritional supplements, including those containing enzymatically enhanced monoglyceride fish oils.
INVIVOCAR Trademark Application - Intent to Use
The USPTO has received an Intent to Use trademark application for the mark 'INVIVOCAR'. The application covers pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and infectious diseases. The filing date was November 12, 2025.
Lifestar Trademark Publication for Opposition
The USPTO has published the Lifestar trademark application for opposition. The application, filed on November 12, 2025, seeks to cover a full line of pharmaceutical and chemical preparations. The publication date is March 22, 2026.
RYOS Trademark Application Filed
The USPTO has received an intent-to-use trademark application for the mark RYOS, filed on November 12, 2025. The application covers goods classified as dietary supplements.
USPTO Trademark Application for AUBRA AX
The USPTO has received an intent-to-use trademark application for 'AUBRA AX', intended for use in connection with oral contraceptives. The application was filed on November 12, 2025.
USPTO Trademark Application Published for Opposition: FOUR MAG
The USPTO has published the trademark application for "FOUR MAG" for opposition. The application, filed on November 12, 2025, covers food supplements and health food supplements. The publication date for opposition is March 22, 2026.
CHATEAL AX Trademark Application - Oral Contraceptives
The USPTO has received a trademark application for 'CHATEAL AX' for use in connection with oral contraceptives. The application was filed on November 12, 2025, under the 'intent to use' provision.
USPTO Intent to Use Trademark Application - JYM
The USPTO has received an Intent to Use trademark application (TM99492435) for the mark 'JYM'. The application covers powdered nutritional supplement drink mixes, protein supplements, and various sports drinks. The filing date for this application was November 12, 2025.
JYM Intent to Use Trademark Application for Energy Drinks
The USPTO has received an intent-to-use trademark application from JYM for various energy and sports drink products. The application was filed on November 12, 2025, and is designated for Class 005, which covers pharmaceuticals and veterinary preparations, but the listed goods are food and beverage items.
USPTO Intent to Use Trademark Application: LUMOBO
The USPTO has received an intent-to-use trademark application for the mark LUMOBO, filed on November 12, 2025. The application pertains to dietary and nutritional supplements.
FITTR Trademark Application Published for Opposition
The USPTO has published the FITTR trademark application for opposition. The application covers online retail services for dietary supplements and fitness products, as well as related business and marketing services. The filing date for this application was November 12, 2025.
CREAMATINE Trademark Published for Opposition
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'CREAMATINE' for opposition. The application covers dietary supplements, dietary and nutritional supplements, and powdered nutritional supplement drink mix. The filing date was November 12, 2025.
Creamatine Trademark Published for Opposition
The USPTO has published the trademark application for 'Creamatine' for opposition. The application, filed on November 12, 2025, covers dietary supplements and related products. The publication date is March 22, 2026.
USPTO Trademark Publication: Be Your Best Body
The USPTO has published the trademark application for 'Be Your Best Body' for opposition. The application covers unprocessed edible seeds and nutritional supplements, filed on November 14, 2025.
USPTO Trademark Application: BE MAGIC, BE YOU
The USPTO has received an intent-to-use trademark application for the mark "BE MAGIC, BE YOU". The application covers dietary supplemental drinks, dietary supplements, and related educational and retail services. The filing date for this application was November 14, 2025.
USPTO Trademark Application: TRIBLOCK 7
The USPTO has received an intent-to-use trademark application for the mark TRIBLOCK 7. The application covers dietary supplements, nutritional supplements, weight management supplements, and dietary and nutritional supplements for weight loss. The filing date was November 14, 2025.
USPTO Trademark Intent to Use Application Filed
The USPTO has received an intent to use trademark application for a wide range of supplements, including probiotic, homeopathic, mineral, herbal, vitamin, and protein-based products. The application was filed on November 12, 2025, for goods intended for use on March 22, 2026.
Green Pulse Intent to Use Trademark Application
The USPTO has received an Intent to Use trademark application for "Green Pulse" filed on November 12, 2025. The application covers a wide range of pharmaceutical and dietary supplement products, including multivitamins, bone and joint supplements, weight loss aids, and sleep aids.
PRODIAMAX Trademark Application Published for Opposition
The USPTO has published the trademark application for PRODIAMAX for opposition. The application covers a range of dietary, nutritional, and herbal supplements for weight management, energy, and general wellness. The filing date was November 12, 2025.
DALICAT Trademark Application Filed
The USPTO has received an intent-to-use trademark application for the mark 'DALICAT'. The application covers a range of pharmaceutical products and supplies for pets, including medicated shampoos, flea and tick treatments, dietary supplements, and dietetic foods for veterinary purposes. The filing date for this application was November 12, 2025.
Yellowbird Intent to Use Trademark Application for Diagnostic Reagents
The USPTO has received an intent-to-use trademark application from Yellowbird for diagnostic reagents and radiopharmaceutical agents. The application covers a range of products used in medical imaging, cancer detection, and general diagnostics.
USPTO Trademark Application - Clinical Diagnostic Reagents
The USPTO has received an intent-to-use trademark application (TM99492783) for clinical diagnostic reagents and related medical imaging agents. The application was filed on November 12, 2025, with an effective date of March 22, 2026.
Prostar Vitamins Trademark Publication
The USPTO has published the Prostar Vitamins trademark application for opposition. The application, filed on November 19, 2025, covers vitamin supplements and was published on March 22, 2026. This publication opens a period for third parties to oppose the trademark registration.
USPTO Trademark Application for CYTOFOOD
The USPTO has received an intent-to-use trademark application (TM99505302) for the mark "CYTOFOOD". The application covers a range of cosmetic products, including anti-aging cleansers, toners, lotions, moisturizers, serums, and facial masks, as well as various dietary and nutritional supplements.
Micromacros Trademark Publication
The USPTO has published the trademark application for "Micromacros" for nutritional supplements. The application was filed on November 19, 2025, and published for opposition on March 22, 2026. This publication is a procedural step in the trademark registration process.
Anointed Inspired Remedies Trademark Application
The USPTO has received an intent-to-use trademark application for 'Anointed Inspired Remedies' by a pharmaceutical company. The application covers goods such as herbal teas, medicinal herbal preparations, and castor oil for medical purposes.
Intelligent Medicines Trademark Published for Opposition
The United States Patent and Trademark Office (USPTO) has published the trademark application for "INTELLIGENT MEDICINES" for opposition. The application covers goods and services related to peptides, nucleotides, medicinals, and regenerative medicine.
USPTO Trademark Application 99505416 Published for Opposition
The USPTO has published trademark application 99505416 for opposition. The application covers peptides, nucleotides, medicinals, and regenerative medicine. The publication date is March 22, 2026, with a filing date of November 19, 2025.
VIOLA Trademark Published for Opposition
The USPTO has published the VIOLA trademark application for opposition. The application covers a range of pharmaceutical and medicinal products, including medicated ointments, skin care preparations, herbal supplements, and medicinal herbs. The publication date is March 22, 2026.
USPTO Trademark Application for ULIFE
The USPTO has received an intent-to-use trademark application for the mark 'ULIFE' filed on November 14, 2025. The application covers dietary supplements, vitamin and mineral supplements, protein supplements, meal replacement drink mixes, and nutraceuticals.
Yellowbird Diagnostics Intent to Use Trademark Application
The USPTO has received an intent-to-use trademark application from Yellowbird Diagnostics for goods and services related to diagnostic reagents, contrast media, and radiopharmaceuticals. The application was filed on November 12, 2025, with an expected use date of March 22, 2026.
USPTO Trademark Application for PR PDRN (POLYDEOXYRIBONUCLEOTIDE SODIUM) 10 G
The USPTO has received an intent-to-use trademark application for 'PR PDRN (POLYDEOXYRIBONUCLEOTIDE SODIUM) 10 G'. The application covers pharmaceutical preparations for skin care, including medicated creams and ointments for dermatological use and treating skin disorders.
USPTO Trademark Application for VYLIBRA AX
The USPTO has received an intent-to-use trademark application for the mark VYLIBRA AX, filed on November 12, 2025. The application is for oral contraceptives. This filing indicates a future intent to use the mark in commerce.
USPTO Trademark Application: TRI-VYLIBRA LO AX
The USPTO has received an intent-to-use trademark application for the mark TRI-VYLIBRA LO AX, filed on November 12, 2025. The application specifies its use in connection with oral contraceptives.
USPTO Trademark Application for TRI-VYLIBRA AX
The USPTO has received an intent-to-use trademark application for the mark TRI-VYLIBRA AX, filed on November 12, 2025. The application is for oral contraceptives.
USPTO Intent to Use Trademark Application for LYLEQ AX
The USPTO has received an intent-to-use trademark application for the mark LYLEQ AX, filed on November 12, 2025. The application is for oral contraceptives. This filing indicates a future intention to use the mark in commerce.
CYRED AX trademark application, intent to use, filed Nov 12, 2025
CYRED AX trademark application, intent to use, filed Nov 12, 2025
USPTO Trademark Application TM99497523 for pharmaceutical preparations
USPTO Trademark Application TM99497523 for pharmaceutical preparations
Bybb Lifestyle Root Powders Trademark Published for Opposition
The USPTO has published the trademark application for 'Bybb Lifestyle Root Powders' for opposition. The application, filed on November 14, 2025, is for nutritional supplements and was published on March 22, 2026. This publication opens a period for third parties to oppose the trademark registration.
STAYSTRONG+ Trademark Application Filed
The USPTO has received an intent-to-use trademark application for STAYSTRONG+ filed on November 12, 2025. The application covers dietary supplements for humans. This filing indicates a future intention to use the mark in commerce.
USPTO Trademark Application for Byheart Baby Food
The USPTO has received an intent-to-use trademark application for 'Byheart' baby food and infant formula. The application was filed on November 13, 2025, and includes the tagline 'THEY’RE NOT IN BREAST MILK, SO THEY’RE NOT IN BYHEART.'
USPTO Trademark Application ANIIREM - Intent to Use
The USPTO has published details for an intent-to-use trademark application (TM99505385) for the mark ANIIREM. The application covers various pharmaceutical and herbal products, including herbal tinctures, medicinal preparations, herbal supplements, castor oil for medical purposes, and tea-based beverages.
USPTO Trademark Application 99496083 - Herbal Supplements
The USPTO has received an intent-to-use trademark application (99496083) for herbal supplements. The application was filed on November 13, 2025, and is designated for use with herbal supplements.
USPTO Trademark Application for IRONMEDS
The USPTO has received an intent-to-use trademark application for the mark IRONMEDS, filed on November 14, 2025. The application covers goods classified as dietary supplements, nutritional supplements, and vitamin supplements.
FORSYNTH Trademark Application - Intent to Use
The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application (TM99497965) for the mark FORSYNTH. The application covers goods and services including dietary supplements, probiotic supplements, and related laboratory research services.
THG Teresa Health General Trademark Published for Opposition
The USPTO has published the trademark application for THG Teresa Health General for dietary supplements. The application was published for opposition on March 22, 2026, following a filing date of November 17, 2025. This publication initiates a period during which other parties may oppose the trademark's registration.
USPTO Trademark Application for Morigella
The USPTO has received an intent-to-use trademark application for the mark "Morigella" by an unnamed applicant. The application covers various dietary supplements and related products. The filing date was November 16, 2025.
KREAFIX Trademark Application - Intent to Use
The USPTO has received an intent-to-use trademark application for the mark KREAFIX, filed on November 19, 2025. The application covers a range of dietary and nutritional supplements, primarily focused on creatine-based products.
Fjor Supplements Trademark Published for Opposition
The USPTO has published the trademark application for 'Fjor Supplements' for opposition. The application covers health food and nutritional supplements for health and wellness. The filing date was November 19, 2025, and the publication date is March 22, 2026.
Louisiana Department of Health Mourns Passing of Former Medicaid Director Ruth Kennedy
The Louisiana Department of Health announced the passing of former Medicaid Director Ruth Kennedy on March 20, 2026. Kennedy served over 40 years in public service, significantly expanding health care access and transforming the state's Medicaid program.
USPTO Intent to Use Trademark Application for Dental Practice Software
The USPTO has received an intent-to-use trademark application for cloud computing software and related services aimed at dental and endodontic practice management. The application covers a broad range of software functionalities, including data management, financial operations, patient scheduling, and educational services.
USPTO Trademark Renewal for Health and Therapy Services
The USPTO has renewed the trademark "Transcending Trauma" (TM97779112), which covers a range of health, therapy, and mental health services. The renewal was effective March 22, 2026, and the original filing date was February 3, 2023.
SUNWORKS ARIZONA Intent to Use Trademark Application
The USPTO has received an intent-to-use trademark application for SUNWORKS ARIZONA. The application, filed on March 20, 2026, covers services including installation and maintenance of irrigation systems, construction of outdoor features, and various landscape and horticultural services.
USPTO Trademark Application: SUNWORKS AZ - Medical Services
The USPTO has received an intent-to-use trademark application (TM99714452) for the mark SUNWORKS AZ. The application covers services related to landscape design, construction, maintenance, and horticultural services, filed on March 20, 2026.
USPTO Trademark Application for One Fleet, Endless Missions
The USPTO has received an intent-to-use trademark application for the mark "One Fleet, Endless Missions." The application covers services including the rental of portable restrooms, portable toilets, and mobile restroom units, as well as maintenance and repair services for these units and towable trailers used as mobile command centers.
USPTO Trademark Application - Monkey Face Tattoos
The USPTO has received an intent-to-use trademark application for "Monkey Face Tattoos" on November 19, 2025. The application covers services including wholesale and retail store services featuring tattoo supplies, tattooing services, cosmetic tattooing, and tattoo studios.
USPTO Trademark Application - LASSO for Dietary Supplements
The USPTO has received an intent-to-use trademark application (TM99506083) for the mark 'LASSO'. The application pertains to providing information about dietary supplements and nutrition, specifically for women's health. The filing date was November 19, 2025.
USPTO Trademark Application for Monkey Face Tattoos
The USPTO has received an intent-to-use trademark application for 'Monkey Face Tattoos' for services including tattooing, tattoo studios, and retail sales of tattoo supplies. The application was filed on November 19, 2025.
USPTO Trademark Application for Monkeyface Tattoos
The USPTO has received an intent-to-use trademark application for "MONKEYFACE MONKEYFACETATTOOS" filed on November 19, 2025. The application covers tattooing services, tattoo studios, parlors, and wholesale/retail store services featuring tattoo supplies.
USPTO Trademark Application for Pediatric Occupational Therapy Educational Materials
The USPTO has received a trademark application (TM99505322) for "intent to use" for printed and downloadable educational materials related to pediatric occupational therapy. The application also covers educational services and occupational therapy services.
Boujee Bouquets Trademark Published for Opposition
The USPTO has published the trademark application for 'Boujee Bouquets Floral Wrap Artistry' for opposition. The application, filed on November 17, 2025, covers floral design services featuring floral bouquets. The publication date was March 22, 2026.
USPTO Trademark Application for CARDITRACK
The USPTO has received an intent-to-use trademark application for the mark CARDITRACK, filed on March 20, 2026. The application covers various software and services related to health monitoring, medical data analysis, and remote health tracking.
Taylor Morgan Trademark Application - Beauty Education and Salon Services
The USPTO has published a trademark application by Taylor Morgan for services including beauty education and salon operations. The application covers live and online classes, workshops, seminars, and events in beauty, hair styling, and cosmetology.
USPTO Trademark Application for Post Excavating & Landscaping
The USPTO has published a trademark application for 'Post Excavating & Landscaping' for services including landscape gardening, design, architecture, and various construction and excavation services. The application was filed on November 12, 2025, and published for opposition on March 22, 2026.
USPTO Trademark Application Published for Opposition: REINS OF LIGHT
The USPTO has published the trademark application for 'REINS OF LIGHT' for opposition. The application covers services including psychic mediumship, Reiki healing, energy healing, and equine-assisted therapy. The publication date is March 22, 2026.
USPTO Trademark Status Change for JN MD
The USPTO has updated the status of trademark application JN MD (TM99185744) on March 22, 2026. The application pertains to health care services, specifically Hormone Rejuvenation Therapy, and was filed on May 14, 2025.
USPTO Trademark Application BF Published for Opposition
The USPTO has published trademark application BF (TM99298867) for opposition. The application, filed on July 23, 2025, seeks to register services related to health spas, resort lodging, restaurants, and various recreational activities. The publication date is March 22, 2026.
USPTO Trademark Application Published for Opposition: Two Stones
The USPTO has published the trademark application for "Two Stones" for opposition. The application covers a wide range of services including entertainment, sports instruction, hospitality, and spa services, primarily offered by a hotel company.
USPTO Trademark Application Published: DR LAURELS
The USPTO has published the trademark application for 'DR LAURELS' for opposition. The application covers dietary supplements and medical spa services. The publication date was March 22, 2026, with a filing date of March 24, 2024.
MOSQUITOCARE Trademark Published for Opposition
The USPTO has published the MOSQUITOCARE trademark application for opposition. The application covers pest control and extermination services. The publication date was March 22, 2026, with a filing date of April 8, 2025.
USPTO Trademark Renewal: CHROMOCYMATICS
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'CHROMOCYMATICS' (TM97608153) for medical services, specifically energy healing and sound healing therapy. The renewal is effective March 22, 2026.
MEDIVEE Trademark Renewal - Cosmetic and IV Therapy Services
The United States Patent and Trademark Office (USPTO) has renewed the MEDIVEE trademark (TM97625141), which covers cosmetic and IV therapy services. The renewal was effective as of March 22, 2026, following a filing date of October 10, 2022.
USPTO Trademark Publication: Rustic Bronzée
The USPTO has published the trademark application for 'Rustic Bronzée' for spray tanning salon services, initiating a 30-day opposition period. The application was filed on March 21, 2026, and published on March 22, 2026.
USPTO Trademark Application for COILISTRY
The USPTO has received an intent-to-use trademark application for the mark COILISTRY. The application, filed on March 20, 2026, covers cosmetic preparations for hair and scalp, information on education, hair replacement services, and clothing layettes.
UNABA Intent to Use Trademark Application
The USPTO has received an intent-to-use trademark application (TM99649397) from UNABA for services including sauna operations, health spa services, and various cosmetic preparations. The application was filed on February 12, 2026.
MENDERS Intent to Use USPTO Trademark Application
The USPTO has received an Intent to Use trademark application (TM99654433) from MENDERS for services including mental health services, psychological counseling, and treatment. The application was filed on February 16, 2026, and is scheduled for review on March 21, 2026.
USPTO Intent to Use Trademark Application for Animal & Health Services
The USPTO has received an Intent to Use trademark application (TM99682659) for a range of animal and health services, including veterinary care, pet grooming, dietary supplements, and pharmaceutical preparations. The application was filed on March 4, 2026, with an intended use date of March 21, 2026.
USPTO Trademark Application for V+ - Animal and Health Services
The USPTO has received an intent-to-use trademark application (TM99682670) for the mark 'V+'. The application covers a wide range of animal and health services, including veterinary care, athletic training, wellness information, pet grooming, dietary supplements, and medicated preparations. The filing date was March 4, 2026.
HYGGEAR Trademark Application - Medical Services
The USPTO has received an intent-to-use trademark application for the mark HYGGEAR, filed on March 21, 2026. The application covers medical care of feet and shiatsu massage services. This filing indicates a future intent to use the mark in commerce.
Catholic Somatics - Intent to Use Trademark Application
The USPTO has received an intent-to-use trademark application (TM99714198) from Catholic Somatics for mental health services. The application was filed on March 20, 2026, with an intended use date of March 21, 2026.
GO WELLBEING Trademark Application for Wellness Program
The USPTO has received an intent-to-use trademark application for 'GO WELLBEING' for health care services, specifically a comprehensive wellness program. The application was filed on March 20, 2026, with an intended use date of March 21, 2026.
CFPA Dr. Bianca Baciu Trademark Renewal
The USPTO has renewed the trademark application TM97466937 for CFPA Dr. Bianca Baciu, which covers various medical and wellness services. The renewal is effective March 22, 2026.
ELIXIR 7 Intent to Use Trademark Application
The USPTO has received an Intent to Use trademark application for 'ELIXIR 7' filed on March 21, 2026. The application covers beauty consultation services related to cosmetics, fragrances, and personal care products.
Brown's Eye Center Trademark Published for Opposition
The USPTO has published the trademark application for 'Brown's Eye Center' for opposition. The application covers retail optical store services and optometry services, with a filing date of March 21, 2026. This publication initiates a period during which third parties may oppose the trademark registration.
YVG BUTTERFLY Trademark Published for Opposition
The USPTO has published the YVG BUTTERFLY trademark application for opposition. The application covers nail lamps, nail gel, and related cosmetic preparations, as well as nail care services. The filing date for this application was November 14, 2025.
USPTO Trademark Published for Opposition: Farm Journal Sustainable Farming
The USPTO has published the trademark application 'Farm Journal Sustainable Farming' for opposition. The application, filed on November 14, 2025, seeks to register the mark for information services in the fields of agriculture, agronomy, conservation, agricultural equipment, agribusiness, and farming. The publication date is March 22, 2026.
USPTO Trademark Publication: Farm Journal Smart Farming
The USPTO has published the trademark application for 'Farm Journal Smart Farming' for opposition. The trademark abstract indicates it will provide information in the fields of agriculture, agribusiness, technology, and farming. The application was filed on November 14, 2025.
MORLIVING Trademark Published for Opposition
The USPTO has published the MORLIVING trademark application for opposition. The application seeks to register the mark for services including personalized healthcare and medical information related to advanced care planning, emergency management, and estate planning. The publication date was March 22, 2026.
USPTO Trademark Publication: SAUNA VILLAGE
The USPTO has published the trademark application for "SAUNA VILLAGE" for opposition. The application, filed on November 19, 2025, covers sauna and cold plunge bath services. The publication date is March 22, 2026.
NBTELEMEDICINE Trademark Published for Opposition
The USPTO has published the NBTELEMEDICINE trademark application for opposition. The application covers medical services provided via telephone and the internet. The publication date is March 22, 2026, with a filing date of November 19, 2025.
USPTO Trademark Application 'Send Teeth, Not Nudes' Published for Opposition
The USPTO has published the trademark application 'Send Teeth, Not Nudes' for opposition. The application, filed on November 19, 2025, seeks to register services related to teeth whitening.
Psych Congress Journal Trademark Application
The USPTO has received an intent-to-use trademark application for 'Psych Congress Journal' on February 3, 2026. The application covers services related to providing healthcare information and online news commentary in the fields of healthcare, medicine, nutrition, and wellness.
USPTO Trademark Application: CINQIQ - Medical Services
The USPTO has received an intent-to-use trademark application for the mark CINQIQ, TM99504154. The application covers services related to health and wellness information, AI-powered outreach, and customer relationship management in the healthcare sector.
Grounded Minds Counseling Trademark Application Published
The United States Patent and Trademark Office (USPTO) has published the trademark application for "Grounded Minds Counseling" for clinical mental health counseling services. The application was filed on November 19, 2025, and published for opposition on March 22, 2026.
Collab HIV Collaboration Network Trademark Application
The USPTO has received an intent-to-use trademark application for 'COLLAB HIV COLLABORATION NETWORK' filed on November 12, 2025. The application covers various educational and informational services related to pharmaceuticals, clinical trials, health, and wellness.
USPTO Trademark Application for Wellness Services Symbol
The USPTO has published a trademark application for a symbol intended for wellness and health-related consulting services. The application, filed on March 21, 2026, covers a wide range of services including health care programs, lifestyle assessments, mental health counseling, and fitness instruction.
The Gentleman Spa Trademark Application
The USPTO has received an intent-to-use trademark application for "The Gentleman Spa" filed on March 22, 2026. The application covers a range of services including cosmetic skin care, barber services, men's grooming, and related non-medicated preparations.
USPTO Trademark Publication: The Curl Cove Organic Clean Curls
The USPTO has published the trademark application 'The Curl Cove Organic Clean Curls' for opposition. The application covers services related to hair salons, hair care, and hair maintenance advice. The publication date is March 22, 2026.
USPTO Trademark Application for TOGETHERLY BY C CINQCARE
The USPTO has received an intent-to-use trademark application for 'TOGETHERLY BY C CINQCARE'. The application covers a broad range of services including case management for individuals with medical conditions, health care coordination, and technology solutions for patients and healthcare providers.
USPTO Trademark Application for Vital Alchemy Integrative Health
The USPTO has received an intent-to-use trademark application for 'Vital Alchemy Integrative Health' filed on March 22, 2026. The application covers services including health counseling, holistic health services, providing health information, and consulting in health and nutrition.
GLAMSQUAD Trademark Application Published for Opposition
The USPTO has published the GLAMSQUAD trademark application for opposition. The application covers beauty services, including hair styling, make-up application, and beauty consultation, as well as related software for coordinating these services. The publication date is March 22, 2026.
USPTO Trademark Publication: Mental Health Therapy Services
The USPTO published a trademark application for "MENTAL WEALTH-CARE" for mental health therapy and counseling services. The application was published for opposition on March 22, 2026, with a filing date of March 21, 2026.
USPTO Trademark Application Filed for Coastal Tanning
The USPTO has received an intent-to-use trademark application for 'Coastal Tanning' for services related to tanning salons. The application was filed on November 12, 2025, and is designated as Kind: intent_to_use.
Athlete Mentals Matter Trademark Application
The USPTO has received an intent-to-use trademark application for "Athlete Mentals Matter" filed on March 21, 2026. The application covers psychological counseling and consulting services in the field of sports psychology.
USPTO Trademark Publication: Metabolism Reset Method
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'Metabolism Reset Method' for opposition. This publication follows the filing date of March 21, 2026, and is a procedural step in the trademark registration process for dietitian services.
Biomastery Trademark Intent to Use Application Filed
The USPTO has received an intent-to-use trademark application for the mark BIOMASTERY. The application covers a wide range of goods and services, including cellular function activating agents, nutritional supplements, intravenous fluids, apparel, and educational services related to functional medicine and optimal human health.
LVY Trademark Application Published for Opposition
The USPTO has published the LVY trademark application for opposition, covering goods and services including livestock, clothing, farming services, and real estate brokerage. The application was filed on November 12, 2025, and published for opposition on March 22, 2026.
USPTO Trademark Application: Root Canal Specialist To The Stars
The USPTO has received an intent-to-use trademark application for 'Root Canal Specialist To The Stars' for dental root canal treatment services. The application was filed on March 21, 2026, under application number TM99716552.
USPTO Trademark Publication: LIVE HEALTHY, LIVE LONG
The USPTO has published the trademark application "LIVE HEALTHY, LIVE LONG" for opposition. The application covers consulting services in mental health, wellness, and personal happiness, as well as online wellness workshops. The filing date was November 19, 2025.
USPTO Intent to Use Trademark for Dental Root Canal Services
The USPTO has received an intent-to-use trademark application for dental root canal services. The application, filed on March 21, 2026, is for services related to dental root canal treatment.
USPTO Trademark Application Published for Opposition
The USPTO has published a trademark application for opposition related to medical services, including integrative medicine training and telehealth consultations. The application was filed on January 15, 2026, and published on March 21, 2026.
USPTO Trademark Published for Opposition: The Acne Nutritionist
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'The Acne Nutritionist' for opposition. The application covers a range of health and wellness services, including nutritional consultancy, online information, and educational materials related to skin health and acne management.
USPTO Trademark Publication: ACNE NUTRITIONIST
The USPTO has published the trademark application for 'ACNE NUTRITIONIST' for opposition. The application covers a wide range of health and wellness services, including nutritional consultancy, online tutorials, and educational content related to nutrition, acne management, and skincare. The publication date is March 21, 2026.
Delphyr AI Software Trademark Application Published
The USPTO has published the trademark application for Delphyr AI software, which offers AI-powered services for clinical documentation, medical record summarization, and workflow automation. The application was published for opposition on March 21, 2026, following a filing date of February 13, 2026.
USPTO Trademark Application for REVIV ALL HOLISTIC HEALTH
The USPTO has published a trademark application for REVIV ALL HOLISTIC HEALTH, covering services such as wellness programs, medical clinic services, and telemedicine. The application was filed on November 14, 2025, and published for opposition on March 22, 2026.
USPTO Trademark Application for 'YOUR BEAUTY, IN THE HANDS OF A WOMAN'
The USPTO has received an intent-to-use trademark application for the mark 'YOUR BEAUTY, IN THE HANDS OF A WOMAN'. The application covers services including regenerative medicine, wellness consulting, beauty consultancy, and providing health and beauty information. The filing date for this application was November 19, 2025.
Monarch Quantum Wellness Trademark Published for Opposition
The USPTO has published the trademark application for 'Monarch Quantum Wellness' for opposition. The application covers a range of holistic health and wellness services, including electromagnetic therapy, biofeedback analysis, and mental wellness counseling. The publication date marks the beginning of a period during which third parties can oppose the trademark registration.
USPTO Trademark Application for POLE TO SOUL
The USPTO has published a new trademark application for "POLE TO SOUL" filed on March 21, 2026. The application seeks to register the mark for various online services, including website design, hosting, optimization, and social media brand marketing.
Apex Endodontics Trademark Application Filed
The USPTO has received an intent-to-use trademark application for 'Apex Endodontics' filed on March 21, 2026. The application covers dental root canal treatment services.
USPTO Trademark Application: ERT Emotional Restoration Technique
The USPTO has received an intent-to-use trademark application for 'ERT Emotional Restoration Technique' filed on March 12, 2025. The application covers educational services related to emotion release therapy and healthcare services for identifying and releasing emotions causing stress.
USPTO Trademark Application: Pediatric Pathways
The USPTO has received an intent-to-use trademark application for 'Pediatric Pathways' filed on March 17, 2025. The application covers pediatric health care services and lactation consulting services. The filing date indicates the application is for future use.
USPTO Trademark Publication: JUDGEMENT FREE THERAPY
The USPTO has published the trademark application "JUDGEMENT FREE THERAPY" for opposition. The application covers various mental health and wellness services, including counseling, therapy, and information provision via website. The publication date is March 22, 2026, with a filing date of August 16, 2025.
USPTO Trademark Application for QUANTUA - Medical Services
The USPTO has received an intent-to-use trademark application (TM98551675) for the mark QUANTUA, filed on May 15, 2024. The application seeks to cover medical analysis services for diagnostic and treatment purposes, specifically urine testing, provided by medical laboratories.
USPTO Trademark Application - Barbering and Grooming Services
The USPTO has received an intent-to-use trademark application (TM99503885) for barbering and men's grooming services, including hair cutting, styling, shaving, and beard maintenance. The application was filed on November 18, 2025.
DEAR DIABETES trademark application published for opposition
The USPTO has published the trademark application for "DEAR DIABETES" for opposition. The application, filed on November 12, 2025, covers a wide range of services related to diabetes education, management, and patient support.
Peabody Health Philanthropies Trademark Published for Opposition
The USPTO has published the trademark application for Peabody Health Philanthropies for opposition. The application covers integrated healthcare services and providing health care information. The filing date was November 11, 2025.
USPTO Trademark Application for Psychotherapy Services
The USPTO has received an intent-to-use trademark application for services related to psychotherapy credentialing verification, medical research, and educational services. The application, filed on November 11, 2025, covers a broad range of activities within the mental health and neuroscience fields.
Neurobridge Assessments Trademark Publication
The USPTO has published the trademark application for 'Neurobridge Assessments' for opposition. The application covers various psychological and health assessment services. The publication date is March 22, 2026.
USPTO Trademark Registration for Ovella Health Medical Services
The USPTO has registered a trademark for Ovella Health, covering medical and telemedicine services related to hormone therapy, perimenopause, and menopause care for women. The trademark was officially registered on March 22, 2026, following a filing date of June 25, 2025.
Frame of Mind Therapy registered trademark Mar 22, 2026
Frame of Mind Therapy registered trademark Mar 22, 2026
USPTO Trademark Application: AUDACIOUS ALPHA
The USPTO has received an intent-to-use trademark application for 'AUDACIOUS ALPHA' filed on November 14, 2024. The application seeks to cover services related to providing consumer information and health information in the fields of cancer treatment and diagnosis.
CROPILOT Trademark Application - Agricultural and Medical Services
The USPTO has received an intent-to-use trademark application for the mark CROPILOT. The application covers a broad range of agricultural services, including equipment rental, advice, pest control, and fertilization, as well as medical services, health information, and veterinary analysis.
USPTO Trademark Application: Holistic Health and Wellness Coaching
The USPTO has received an intent-to-use trademark application for "THE TRUTHBRITOLD HOLISTIC HEALTH AND WELLNESS" for services including health and wellness coaching, mental health counseling, and lifestyle wellness counseling. The application was filed on May 22, 2024, with an intended use date of March 22, 2026.
USPTO Trademark Application for REPERIOCARE - Medical Services
The USPTO has received an intent-to-use trademark application for the mark REPERIOCARE. The application covers a broad range of healthcare and medical services, including virtual and remote care, telemedicine, and mental health services. The filing date was June 10, 2024.
Shemayah Intent to Use Trademark Application
The USPTO has received an Intent to Use trademark application (TM98862714) from Shemayah for services including energy healing, therapeutic touch, and holistic health featuring herbal medicine. The application was filed on November 20, 2024, and is designated for Class 044, which covers medical services.
USPTO Trademark Application - Home Harmony Aba
The USPTO has received an intent-to-use trademark application (TM99316841) for 'Home Harmony Aba'. The application covers behavioral health services, occupational therapy, speech therapy, and physical therapy. The filing date was August 2, 2025.
HOME ABA Intent to Use Trademark Application for Behavioral Health Services
The USPTO has received an intent-to-use trademark application from HOME ABA for services including behavioral health, occupational therapy, speech therapy, and physical therapy. The application was filed on August 2, 2025, with an expected use date of March 22, 2026.
USPTO Intent to Use Trademark Application ELAVATE
The USPTO has received an intent-to-use trademark application (TM99182468) for the mark 'ELAVATE'. The application covers medical services, dental services, oral health care services, cosmetic dentistry, cosmetic preparations for oral care, toothpaste, and non-medicated mouthwashes and rinses.
THEBEAUTYSHARK Trademark Published for Opposition
The USPTO has published the trademark application for 'THEBEAUTYSHARK' for opposition, related to beauty consultancy services. The application was filed on September 21, 2025, and published on March 22, 2026.
Marsmade Intent to Use Trademark Application Filed
The USPTO has received an intent-to-use trademark application for the mark MARSMADE. The application covers a broad range of medical, health, and beauty services, including nutrition counseling, medical advisory services, and beauty salons. The filing date for this application was October 12, 2025.
USPTO Trademark Application for Simple Lenses
The USPTO has received an intent-to-use trademark application for "SIMPLE LENSES" filed on October 21, 2025. The application covers optician services and various types of lenses, including eyeglass, ophthalmic, optical, sunglass, and antireflective lenses, as well as carrying cases for contact lenses.
BABE, IT AIN'T EASY Trademark Application for Business Services
The USPTO has received an intent-to-use trademark application for the mark 'BABE, IT AIN'T EASY' for business services related to connecting consumers with caregivers in health, childcare, and senior care. The application was filed on October 21, 2025, with an intended use date of March 22, 2026.
USPTO Trademark Application - The Mane Revue
The USPTO has received an intent-to-use trademark application for 'The Mane Revue' filed on October 21, 2025. The application abstract indicates the mark will be used for providing information about beauty via social media websites.
Children's Neuropsychology Center Trademark Published
The USPTO has published the trademark application for 'The Children's Neuropsychology Center' for psychological assessment services in pediatric neuropsychology and childhood developmental disorders. The application was published for opposition on March 22, 2026, with a filing date of November 7, 2025.
USPTO Trademark Publication: CRABAPPLE DENTAL
The USPTO has published the trademark application for 'CRABAPPLE DENTAL' for opposition. The application covers various dental care services, including oral surgery, implant services, and gum treatments. The filing date for this application was November 14, 2025.
Adonai Behavioral Solutions Trademark Publication
The USPTO has published the trademark application for 'Adonai Behavioral Solutions' for mental health services. The application was filed on November 14, 2025, and published on March 22, 2026, initiating a period for opposition.
RAENARA Trademark Application Published for Opposition
The USPTO has published the RAENARA trademark application for opposition. The application, filed on November 12, 2025, seeks to register services related to acupuncture.
IKKIE Trademark Application for Medical and Beauty Services
The USPTO has received an intent-to-use trademark application from IKKIE for a range of medical, beauty, and related technology services. The application covers services including medical clinics, dentistry, nursing homes, hospitals, beauty salons, and consulting, as well as various equipment and software.
Town Animal Hospital Trademark Published for Opposition
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'TOWN ANIMAL HOSPITAL' for opposition. The application, filed on November 12, 2025, covers veterinary services and was published on March 22, 2026.
USPTO Trademark Application for Springfield Smiles Family Dentistry
The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for 'Springfield Smiles Family Dentistry, TMJ & Sleep Center'. The application covers various dental services, including prosthetic dentistry, cosmetic dentistry, and sedation dentistry.
DEAR DIABETES Trademark Publication for Opposition
The USPTO has published the trademark application 'DEAR DIABETES' for opposition. The application covers a wide range of services related to diabetes education, management, and patient support. The filing date was November 12, 2025.
Vyora Aesthetics Trademark Application Filed
The USPTO has received an intent-to-use trademark application for 'Vyora Aesthetics' on November 12, 2025. The application covers medical spa services, specifically minimally and non-invasive cosmetic and body fitness therapies. This filing indicates a potential new market entrant in the aesthetic services sector.
Bronxium Transition Rough Element Trademark Filing
The USPTO has received a trademark filing for 'Bronxium Transition Rough Element' under the 'Intent to Use' application type. The filing pertains to medical, physical rehabilitation, and physical therapy services.
USPTO Trademark Application: PATIENTS FIRST
The USPTO has received an intent-to-use trademark application for "PATIENTS FIRST" filed on March 22, 2026. The application covers wholesale distribution of pharmaceutical products and medical devices, as well as providing health information and educational services related to medication adherence and patient safety.
USPTO Trademark Publication for Advanced Sonography Screening LLC
The USPTO has published a trademark application for Advanced Sonography Screening LLC, covering medical ultrasound imaging and health screening services. The trademark was published for opposition on March 22, 2026, with a filing date of November 14, 2025.
USPTO Trademark Application Published for Women's Therapy Clinic
The USPTO has published a trademark application for "Women's Therapy Clinic" for mental health therapy services. The application was published for opposition on March 22, 2026, with a filing date of November 14, 2025.
NEUROLOUNGE Trademark Application - Medical Services
The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for the mark NEUROLOUNGE. The application covers a range of medical, wellness, and hospitality services, including stress reduction therapy and cognitive therapy.
Tanner Health Trademark Application Published
The USPTO has published the trademark application for 'TANNER HEALTH' for opposition. The application, filed on November 12, 2025, covers health care services and was published on March 22, 2026.
MARCY K SALON Trademark Publication
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'MARCY K SALON' for opposition. The application covers services including beauty salon, hair salon, cosmetic eyebrow care, eyelash extension, nail care, and cosmetology services.
DIAGNOVET Trademark Application Published for Opposition
The USPTO has published the trademark application for 'DIAGNOVET' for opposition. The application covers a wide range of services including veterinary research, software development for AI and machine learning, and various veterinary medical services. The filing date was November 13, 2025.
Magellan Crisis Connect 360 Trademark Published for Opposition
The USPTO has published the trademark application for 'Magellan Crisis Connect 360' for opposition. The application covers behavioral health services, including crisis call center operations, care coordination, and mental health crisis response.
USPTO Trademark Application for Coastal Sun Spa
The USPTO has received an intent-to-use trademark application for 'Coastal Sun Spa' filed on November 17, 2025. The application, TM99500162, is for services including tanning salons. The filing date indicates the application is now officially registered in the system.
USPTO Trademark Application Published for Opposition
The USPTO has published trademark application TM99505159 for opposition. The application, filed on November 19, 2025, covers various medical and beauty services including massage, spa treatments, and facials. The publication date is March 22, 2026.
Orange County Plastic Surgery Trademark Publication
The USPTO has published the trademark application for "ORANGE COUNTY PLASTIC SURGERY" for opposition. The application covers services including plastic surgery, cosmetic surgery, and medical spa services. This publication opens a period for third parties to oppose the trademark registration.
USPTO Trademark Application - Casavita Pace Center
The USPTO has received an intent-to-use trademark application from Casavita Pace Center for services including health care, home health care, and geriatric health care management. The application was filed on November 19, 2025, and is designated for use by healthcare providers.
Green Space Herbs Trademark Application Filed
The USPTO has received an intent-to-use trademark application for "Green Space Herbs" filed on December 2, 2025. The application covers medical services, healthcare consulting, dietetic advisory services, and nutritional consultancy.
USPTO Trademark Application for Facyal Skin Experts
The USPTO has received an intent-to-use trademark application (TM99504344) for 'Facyal Skin Experts' filed on November 19, 2025. The application covers medspa services, cosmetic skin care, and skin care salon services.